Pathway,P-value,Contrast,-log10Pvalue,Pathway Name
hsa05225,2.386557009786098e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.622228186799604,Hepatocellular carcinoma
hsa04962,0.4854028921134373,"1% O2, CyA+ vs 1% O2, CyA-",0.3138976403955859,Vasopressin-regulated water reabsorption
hsa03250,4.3984496666043753e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.356700373487685,Viral life cycle - HIV-1
hsa04912,0.00021003931778362418,"1% O2, CyA+ vs 1% O2, CyA-",3.677699400989097,GnRH signaling pathway
hsa05218,0.007950786418058202,"1% O2, CyA+ vs 1% O2, CyA-",2.0995899128363913,Melanoma
hsa00100,5.289224835589191e-29,"1% O2, CyA+ vs 1% O2, CyA-",28.27660797149863,Steroid biosynthesis
hsa00830,0.4733382781033767,"1% O2, CyA+ vs 1% O2, CyA-",0.3248283734173233,Retinol metabolism
hsa00785,0.5467381708937606,"1% O2, CyA+ vs 1% O2, CyA-",0.26222060448811246,Lipoic acid metabolism
hsa04625,1.0512493428500214e-16,"1% O2, CyA+ vs 1% O2, CyA-",15.978294262677217,C-type lectin receptor signaling pathway
hsa05221,0.006905841343725385,"1% O2, CyA+ vs 1% O2, CyA-",2.160783403446177,Acute myeloid leukemia
hsa04145,0.0051253216471960055,"1% O2, CyA+ vs 1% O2, CyA-",2.290278874619713,Phagosome
hsa05217,0.24924420984505108,"1% O2, CyA+ vs 1% O2, CyA-",0.6033749219292535,Basal cell carcinoma
hsa05223,0.09861897702025552,"1% O2, CyA+ vs 1% O2, CyA-",1.0060395067406178,Non-small cell lung cancer
hsa05330,0.5429738992409554,"1% O2, CyA+ vs 1% O2, CyA-",0.2652210464481124,Allograft rejection
hsa04022,0.01045815761884426,"1% O2, CyA+ vs 1% O2, CyA-",1.980544817040838,cGMP-PKG signaling pathway
hsa00140,0.5022540918356565,"1% O2, CyA+ vs 1% O2, CyA-",0.29907651639273936,Steroid hormone biosynthesis
hsa04066,2.0800119086661096e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.6819341785693664,HIF-1 signaling pathway
hsa04724,0.44063839539780136,"1% O2, CyA+ vs 1% O2, CyA-",0.3559176629208768,Glutamatergic synapse
hsa05012,0.3069610815554794,"1% O2, CyA+ vs 1% O2, CyA-",0.5129166836014097,Parkinson disease
hsa05146,0.43903979662507037,"1% O2, CyA+ vs 1% O2, CyA-",0.357496111486088,Amoebiasis
hsa05410,0.3894440104329844,"1% O2, CyA+ vs 1% O2, CyA-",0.409554971130937,Hypertrophic cardiomyopathy
hsa00510,0.47108819754855186,"1% O2, CyA+ vs 1% O2, CyA-",0.32689777626218114,N-Glycan biosynthesis
hsa04114,1.1333270297874718e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.9456447532092875,Oocyte meiosis
hsa04310,0.009041092640724453,"1% O2, CyA+ vs 1% O2, CyA-",2.043779080679262,Wnt signaling pathway
hsa03015,5.990732369570501e-19,"1% O2, CyA+ vs 1% O2, CyA-",18.222520081680695,mRNA surveillance pathway
hsa03440,0.15046973937940755,"1% O2, CyA+ vs 1% O2, CyA-",0.8225508312457813,Homologous recombination
hsa05152,0.12695969209201324,"1% O2, CyA+ vs 1% O2, CyA-",0.8963341395211804,Tuberculosis
hsa04110,0.07752580666505776,"1% O2, CyA+ vs 1% O2, CyA-",1.1105537061824038,Cell cycle
hsa00604,0.5241903666957344,"1% O2, CyA+ vs 1% O2, CyA-",0.28051096455944446,Glycosphingolipid biosynthesis - ganglio series
hsa05416,0.014238786259310784,"1% O2, CyA+ vs 1% O2, CyA-",1.8465270291928093,Viral myocarditis
hsa04664,1.7797540341051715e-26,"1% O2, CyA+ vs 1% O2, CyA-",25.74964001398999,Fc epsilon RI signaling pathway
hsa04929,3.686335573633275e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.433405132724211,GnRH secretion
hsa04136,2.4179267591563464e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.61655685838674,Autophagy - other
hsa04660,3.181892448706233e-10,"1% O2, CyA+ vs 1% O2, CyA-",9.49731450404921,T cell receptor signaling pathway
hsa00310,0.0025888770355144246,"1% O2, CyA+ vs 1% O2, CyA-",2.5868885768597507,Lysine degradation
hsa04070,0.3345445614381858,"1% O2, CyA+ vs 1% O2, CyA-",0.47554602588493544,Phosphatidylinositol signaling system
hsa04726,0.004308806371004007,"1% O2, CyA+ vs 1% O2, CyA-",2.365643021783976,Serotonergic synapse
hsa05332,0.5381079781210834,"1% O2, CyA+ vs 1% O2, CyA-",0.2691305689490888,Graft-versus-host disease
hsa04916,0.0020320733442659414,"1% O2, CyA+ vs 1% O2, CyA-",2.692060620977129,Melanogenesis
hsa05169,0.15910719251643535,"1% O2, CyA+ vs 1% O2, CyA-",0.7983101874207076,Epstein-Barr virus infection
hsa00900,0.0219678360971013,"1% O2, CyA+ vs 1% O2, CyA-",1.6582127203836319,Terpenoid backbone biosynthesis
hsa00591,0.5174490464009375,"1% O2, CyA+ vs 1% O2, CyA-",0.2861324090718047,Linoleic acid metabolism
hsa04024,0.02828129197819396,"1% O2, CyA+ vs 1% O2, CyA-",1.5485007544867435,cAMP signaling pathway
hsa04068,1.4740314149864497e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.831493260567959,FoxO signaling pathway
hsa00520,0.30444959782124853,"1% O2, CyA+ vs 1% O2, CyA-",0.5164845953132782,Amino sugar and nucleotide sugar metabolism
hsa00860,0.4696394878161954,"1% O2, CyA+ vs 1% O2, CyA-",0.3282353942568475,Porphyrin metabolism
hsa04922,8.243130502770395e-09,"1% O2, CyA+ vs 1% O2, CyA-",8.083907824481857,Glucagon signaling pathway
hsa04926,0.04088676387473853,"1% O2, CyA+ vs 1% O2, CyA-",1.3884172618340527,Relaxin signaling pathway
hsa04370,5.5573776492646194e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.25513008991267,VEGF signaling pathway
hsa05213,2.1585060980975547e-20,"1% O2, CyA+ vs 1% O2, CyA-",19.66584672006012,Endometrial cancer
hsa04520,2.048603207150517e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.6885421517172405,Adherens junction
hsa05110,0.00557304716607664,"1% O2, CyA+ vs 1% O2, CyA-",2.2539072813866246,Vibrio cholerae infection
hsa05220,0.011072269780088654,"1% O2, CyA+ vs 1% O2, CyA-",1.9557633410072195,Chronic myeloid leukemia
hsa05235,2.2834539747136963e-09,"1% O2, CyA+ vs 1% O2, CyA-",8.641407737606055,PD-L1 expression and PD-1 checkpoint pathway in cancer
hsa05207,0.0003178093805519082,"1% O2, CyA+ vs 1% O2, CyA-",3.4978332881802228,Chemical carcinogenesis - receptor activation
hsa05418,0.1856970944519064,"1% O2, CyA+ vs 1% O2, CyA-",0.7311948914857226,Fluid shear stress and atherosclerosis
hsa00920,0.5260781268898181,"1% O2, CyA+ vs 1% O2, CyA-",0.27894975478625134,Sulfur metabolism
hsa04931,0.0001075755016580555,"1% O2, CyA+ vs 1% O2, CyA-",3.9682866199903075,Insulin resistance
hsa00500,0.029594369270626624,"1% O2, CyA+ vs 1% O2, CyA-",1.528790911485518,Starch and sucrose metabolism
hsa05216,0.413889761373307,"1% O2, CyA+ vs 1% O2, CyA-",0.38311531685624256,Thyroid cancer
hsa00740,0.41657731639088375,"1% O2, CyA+ vs 1% O2, CyA-",0.3803043820946554,Riboflavin metabolism
hsa00062,0.23814831682609044,"1% O2, CyA+ vs 1% O2, CyA-",0.623152483628453,Fatty acid elongation
hsa04390,0.017639580776440393,"1% O2, CyA+ vs 1% O2, CyA-",1.7535117405557923,Hippo signaling pathway
hsa04064,0.20049933852484364,"1% O2, CyA+ vs 1% O2, CyA-",0.6978870558392313,NF-kappa B signaling pathway
hsa04932,0.2615897829856664,"1% O2, CyA+ vs 1% O2, CyA-",0.5823792224257447,Non-alcoholic fatty liver disease
hsa05222,0.04071515865501503,"1% O2, CyA+ vs 1% O2, CyA-",1.3902438685498053,Small cell lung cancer
hsa05320,0.5558259805555025,"1% O2, CyA+ vs 1% O2, CyA-",0.25506115718407685,Autoimmune thyroid disease
hsa04115,0.04790357855566249,"1% O2, CyA+ vs 1% O2, CyA-",1.3196320421402175,p53 signaling pathway
hsa04710,0.16026983018373403,"1% O2, CyA+ vs 1% O2, CyA-",0.7951482232346745,Circadian rhythm
hsa05206,0.0006646172961268614,"1% O2, CyA+ vs 1% O2, CyA-",3.177428360748082,MicroRNAs in cancer
hsa05032,0.471311616823057,"1% O2, CyA+ vs 1% O2, CyA-",0.3266918556785678,Morphine addiction
hsa00620,0.33322384337416006,"1% O2, CyA+ vs 1% O2, CyA-",0.4772639308086225,Pyruvate metabolism
hsa05132,0.19713626798764194,"1% O2, CyA+ vs 1% O2, CyA-",0.7052334693891202,Salmonella infection
hsa04658,0.14171855613862794,"1% O2, CyA+ vs 1% O2, CyA-",0.8485732810087787,Th1 and Th2 cell differentiation
hsa05014,0.035159077301835234,"1% O2, CyA+ vs 1% O2, CyA-",1.453962530867309,Amyotrophic lateral sclerosis
hsa04933,0.4763792521258946,"1% O2, CyA+ vs 1% O2, CyA-",0.3220471617221207,AGE-RAGE signaling pathway in diabetic complications
hsa00531,0.4853475249610821,"1% O2, CyA+ vs 1% O2, CyA-",0.3139471807271679,Glycosaminoglycan degradation
hsa04714,0.06837987895044206,"1% O2, CyA+ vs 1% O2, CyA-",1.1650716723490406,Thermogenesis
hsa00592,0.4666651621754954,"1% O2, CyA+ vs 1% O2, CyA-",0.3309946191698537,alpha-Linolenic acid metabolism
hsa05170,8.33508060748401e-08,"1% O2, CyA+ vs 1% O2, CyA-",7.079090195810034,Human immunodeficiency virus 1 infection
hsa05160,3.1266570430220646e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.504919753068374,Hepatitis C
hsa04392,0.05820927358110588,"1% O2, CyA+ vs 1% O2, CyA-",1.2350078204314183,Hippo signaling pathway - multiple species
hsa04666,0.000594620534669522,"1% O2, CyA+ vs 1% O2, CyA-",3.2257600969143465,Fc gamma R-mediated phagocytosis
hsa04920,0.062307326998712165,"1% O2, CyA+ vs 1% O2, CyA-",1.2054608796970903,Adipocytokine signaling pathway
hsa04940,0.5511772685875033,"1% O2, CyA+ vs 1% O2, CyA-",0.2587087017146929,Type I diabetes mellitus
hsa04672,0.07649227893663749,"1% O2, CyA+ vs 1% O2, CyA-",1.1163823999371323,Intestinal immune network for IgA production
hsa00780,0.5233070802330998,"1% O2, CyA+ vs 1% O2, CyA-",0.28124338930894105,Biotin metabolism
hsa00590,0.3119270556507808,"1% O2, CyA+ vs 1% O2, CyA-",0.5059469541616187,Arachidonic acid metabolism
hsa05161,0.01999023716004142,"1% O2, CyA+ vs 1% O2, CyA-",1.6991820534713606,Hepatitis B
hsa04540,1.972870689464998e-42,"1% O2, CyA+ vs 1% O2, CyA-",41.70490137936626,Gap junction
hsa04913,0.15801059892114627,"1% O2, CyA+ vs 1% O2, CyA-",0.8013137807760561,Ovarian steroidogenesis
hsa05212,0.26553751820572985,"1% O2, CyA+ vs 1% O2, CyA-",0.5758741081095686,Pancreatic cancer
hsa05211,2.6312952103131113e-271,"1% O2, CyA+ vs 1% O2, CyA-",270.5798304248076,Renal cell carcinoma
hsa04371,0.0009988329404875612,"1% O2, CyA+ vs 1% O2, CyA-",3.000507143497222,Apelin signaling pathway
hsa05164,0.05738064595429894,"1% O2, CyA+ vs 1% O2, CyA-",1.2412345670553646,Influenza A
hsa04146,0.06876590463731942,"1% O2, CyA+ vs 1% O2, CyA-",1.162626839353989,Peroxisome
hsa04122,3.8868354987206715e-19,"1% O2, CyA+ vs 1% O2, CyA-",18.410403839484417,Sulfur relay system
hsa05167,0.28289677712765615,"1% O2, CyA+ vs 1% O2, CyA-",0.5483720001699007,Kaposi sarcoma-associated herpesvirus infection
hsa00562,0.4292124413469064,"1% O2, CyA+ vs 1% O2, CyA-",0.36732769786638897,Inositol phosphate metabolism
hsa04935,0.0004937473539588196,"1% O2, CyA+ vs 1% O2, CyA-",3.3064952187865724,"Growth hormone synthesis, secretion and action"
hsa00240,0.2901626038521912,"1% O2, CyA+ vs 1% O2, CyA-",0.5373585601517592,Pyrimidine metabolism
hsa05200,0.24168128708358494,"1% O2, CyA+ vs 1% O2, CyA-",0.6167569748755809,Pathways in cancer
hsa00480,0.38234020172695093,"1% O2, CyA+ vs 1% O2, CyA-",0.4175500350433601,Glutathione metabolism
hsa04150,8.145665664704631e-08,"1% O2, CyA+ vs 1% O2, CyA-",7.089073419311853,mTOR signaling pathway
hsa05034,5.02842406849888e-09,"1% O2, CyA+ vs 1% O2, CyA-",8.298568103531258,Alcoholism
hsa04750,0.17651176013580466,"1% O2, CyA+ vs 1% O2, CyA-",0.7532263543444699,Inflammatory mediator regulation of TRP channels
hsa04137,0.07429580805555139,"1% O2, CyA+ vs 1% O2, CyA-",1.129035689465549,Mitophagy - animal
hsa05203,0.0003581046540180355,"1% O2, CyA+ vs 1% O2, CyA-",3.4459900347512433,Viral carcinogenesis
hsa03320,0.4660456277265671,"1% O2, CyA+ vs 1% O2, CyA-",0.3315715620657684,PPAR signaling pathway
hsa00564,0.4832063256372802,"1% O2, CyA+ vs 1% O2, CyA-",0.3158673890156838,Glycerophospholipid metabolism
hsa04961,0.4672467893390154,"1% O2, CyA+ vs 1% O2, CyA-",0.3304536741698677,Endocrine and other factor-regulated calcium reabsorption
hsa00220,0.5059067829673317,"1% O2, CyA+ vs 1% O2, CyA-",0.29592949773012606,Arginine biosynthesis
hsa05168,5.491190672112847e-30,"1% O2, CyA+ vs 1% O2, CyA-",29.26033347590294,Herpes simplex virus 1 infection
hsa04061,0.002839531808320103,"1% O2, CyA+ vs 1% O2, CyA-",2.5467532620041085,Viral protein interaction with cytokine and cytokine receptor
hsa05412,0.3627228937834677,"1% O2, CyA+ vs 1% O2, CyA-",0.4404250324260418,Arrhythmogenic right ventricular cardiomyopathy
hsa04924,0.004161211829576376,"1% O2, CyA+ vs 1% O2, CyA-",2.3807801755614117,Renin secretion
hsa05143,0.4686864347128585,"1% O2, CyA+ vs 1% O2, CyA-",0.32911761617171886,African trypanosomiasis
hsa04960,0.02724861360529999,"1% O2, CyA+ vs 1% O2, CyA-",1.564655589493212,Aldosterone-regulated sodium reabsorption
hsa05162,0.3617704617278483,"1% O2, CyA+ vs 1% O2, CyA-",0.44156689582970643,Measles
hsa00730,0.4330461799901159,"1% O2, CyA+ vs 1% O2, CyA-",0.36346578806817215,Thiamine metabolism
hsa05030,0.25185260526760467,"1% O2, CyA+ vs 1% O2, CyA-",0.5988535522611342,Cocaine addiction
hsa00750,0.3890439030413022,"1% O2, CyA+ vs 1% O2, CyA-",0.4100013864051336,Vitamin B6 metabolism
hsa04623,0.22315895939872893,"1% O2, CyA+ vs 1% O2, CyA-",0.6513856723936077,Cytosolic DNA-sensing pathway
hsa00650,0.3929682343262966,"1% O2, CyA+ vs 1% O2, CyA-",0.40564255449575853,Butanoate metabolism
hsa05010,0.040749785462232284,"1% O2, CyA+ vs 1% O2, CyA-",1.3898746733734266,Alzheimer disease
hsa05031,0.18908370343518788,"1% O2, CyA+ vs 1% O2, CyA-",0.7233459000981537,Amphetamine addiction
hsa00071,0.09917849929615452,"1% O2, CyA+ vs 1% O2, CyA-",1.0035824674537608,Fatty acid degradation
hsa00561,0.3970360208577819,"1% O2, CyA+ vs 1% O2, CyA-",0.40117009033986795,Glycerolipid metabolism
hsa04614,0.04081064322871159,"1% O2, CyA+ vs 1% O2, CyA-",1.3892265601280138,Renin-angiotensin system
hsa04971,0.0001760869228898211,"1% O2, CyA+ vs 1% O2, CyA-",3.754272895751475,Gastric acid secretion
hsa04215,0.04322321167297528,"1% O2, CyA+ vs 1% O2, CyA-",1.3642829662813463,Apoptosis - multiple species
hsa04080,0.3638063561097089,"1% O2, CyA+ vs 1% O2, CyA-",0.43912971758903074,Neuroactive ligand-receptor interaction
hsa05231,0.08659000573839482,"1% O2, CyA+ vs 1% O2, CyA-",1.0625322315755494,Choline metabolism in cancer
hsa05166,5.556053457958544e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.255233584319462,Human T-cell leukemia virus 1 infection
hsa00790,0.17830337817237374,"1% O2, CyA+ vs 1% O2, CyA-",0.7488404285143675,Folate biosynthesis
hsa00983,0.23804548695124877,"1% O2, CyA+ vs 1% O2, CyA-",0.6233400477990005,Drug metabolism - other enzymes
hsa04721,0.20619392702333406,"1% O2, CyA+ vs 1% O2, CyA-",0.6857241300277427,Synaptic vesicle cycle
hsa04218,4.200363289208101e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.3767131458698945,Cellular senescence
hsa04530,0.20521876645965764,"1% O2, CyA+ vs 1% O2, CyA-",0.6877829271995385,Tight junction
hsa04340,0.048904728141061754,"1% O2, CyA+ vs 1% O2, CyA-",1.3106491509723452,Hedgehog signaling pathway
hsa04725,0.06767625162371387,"1% O2, CyA+ vs 1% O2, CyA-",1.16956370351836,Cholinergic synapse
hsa04740,0.5408352675017515,"1% O2, CyA+ vs 1% O2, CyA-",0.26693499609378435,Olfactory transduction
hsa04152,2.791283433955156e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.55419606191593,AMPK signaling pathway
hsa03460,1.0053920069123382e-64,"1% O2, CyA+ vs 1% O2, CyA-",63.9976645718309,Fanconi anemia pathway
hsa05214,0.0009260553645614839,"1% O2, CyA+ vs 1% O2, CyA-",3.0333630480861262,Glioma
hsa00440,0.5283503256356793,"1% O2, CyA+ vs 1% O2, CyA-",0.27707802057382863,Phosphonate and phosphinate metabolism
hsa04020,0.11709593391420631,"1% O2, CyA+ vs 1% O2, CyA-",0.931458185280176,Calcium signaling pathway
hsa04514,0.37317132933271946,"1% O2, CyA+ vs 1% O2, CyA-",0.42809173038883774,Cell adhesion molecules
hsa04613,0.09810771961613574,"1% O2, CyA+ vs 1% O2, CyA-",1.0082968187690078,Neutrophil extracellular trap formation
hsa00250,0.4421441197291629,"1% O2, CyA+ vs 1% O2, CyA-",0.3544361464854615,"Alanine, aspartate and glutamate metabolism"
hsa04217,0.11886427070194533,"1% O2, CyA+ vs 1% O2, CyA-",0.9249486699303369,Necroptosis
hsa04934,1.0134167733178735e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.994211911867816,Cushing syndrome
hsa05140,0.05921882634145493,"1% O2, CyA+ vs 1% O2, CyA-",1.2275402041483532,Leishmaniasis
hsa04919,3.66338588570582e-08,"1% O2, CyA+ vs 1% O2, CyA-",7.436117332166505,Thyroid hormone signaling pathway
hsa04550,0.23952530376528064,"1% O2, CyA+ vs 1% O2, CyA-",0.6206486003907495,Signaling pathways regulating pluripotency of stem cells
hsa00061,0.02876459144030356,"1% O2, CyA+ vs 1% O2, CyA-",1.5411417901238562,Fatty acid biosynthesis
hsa00532,0.4329388016863861,"1% O2, CyA+ vs 1% O2, CyA-",0.3635734892547094,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
hsa04742,0.3004111356293837,"1% O2, CyA+ vs 1% O2, CyA-",0.5222839729569512,Taste transduction
hsa04261,0.09765482272124992,"1% O2, CyA+ vs 1% O2, CyA-",1.0103063040452782,Adrenergic signaling in cardiomyocytes
hsa04910,3.616906290113529e-12,"1% O2, CyA+ vs 1% O2, CyA-",11.441662743163679,Insulin signaling pathway
hsa04015,0.0023222958289988186,"1% O2, CyA+ vs 1% O2, CyA-",2.63408245784537,Rap1 signaling pathway
hsa05208,1.6351735733276229e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.786436140289712,Chemical carcinogenesis - reactive oxygen species
hsa04914,1.7531828989856404e-70,"1% O2, CyA+ vs 1% O2, CyA-",69.75617277422181,Progesterone-mediated oocyte maturation
hsa04130,0.1474776727909785,"1% O2, CyA+ vs 1% O2, CyA-",0.8312737242121826,SNARE interactions in vesicular transport
hsa00640,0.13330579448052865,"1% O2, CyA+ vs 1% O2, CyA-",0.8751509724449182,Propanoate metabolism
hsa00450,0.4450429028859061,"1% O2, CyA+ vs 1% O2, CyA-",0.35159812028091936,Selenocompound metabolism
hsa04621,0.0018371049789553525,"1% O2, CyA+ vs 1% O2, CyA-",2.7358660257963368,NOD-like receptor signaling pathway
hsa05130,0.05641095597273606,"1% O2, CyA+ vs 1% O2, CyA-",1.2486365404063877,Pathogenic Escherichia coli infection
hsa04670,0.1569935298769018,"1% O2, CyA+ vs 1% O2, CyA-",0.8041182456586677,Leukocyte transendothelial migration
hsa04928,0.03002778311474353,"1% O2, CyA+ vs 1% O2, CyA-",1.5224767296249626,"Parathyroid hormone synthesis, secretion and action"
hsa00130,0.427186006941893,"1% O2, CyA+ vs 1% O2, CyA-",0.3693829816523738,Ubiquinone and other terpenoid-quinone biosynthesis
hsa05100,0.12504510394521162,"1% O2, CyA+ vs 1% O2, CyA-",0.9029333081014486,Bacterial invasion of epithelial cells
hsa05414,0.43920316920271185,"1% O2, CyA+ vs 1% O2, CyA-",0.35733453476405747,Dilated cardiomyopathy
hsa05321,0.44741484431241824,"1% O2, CyA+ vs 1% O2, CyA-",0.349289610994812,Inflammatory bowel disease
hsa00051,0.07136424073451127,"1% O2, CyA+ vs 1% O2, CyA-",1.146519350435813,Fructose and mannose metabolism
hsa05230,1.1365450901517478e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.94441332983286,Central carbon metabolism in cancer
hsa04727,0.3736654418334071,"1% O2, CyA+ vs 1% O2, CyA-",0.4275170656907848,GABAergic synapse
hsa04630,0.0019460484311984976,"1% O2, CyA+ vs 1% O2, CyA-",2.710846355670684,JAK-STAT signaling pathway
hsa00603,0.5641023047314666,"1% O2, CyA+ vs 1% O2, CyA-",0.24864212589043067,Glycosphingolipid biosynthesis - globo and isoglobo series
hsa00340,0.33786246626594496,"1% O2, CyA+ vs 1% O2, CyA-",0.471260052081239,Histidine metabolism
hsa04610,0.4796206221744671,"1% O2, CyA+ vs 1% O2, CyA-",0.31910215187837826,Complement and coagulation cascades
hsa05205,0.01981812855838915,"1% O2, CyA+ vs 1% O2, CyA-",1.7029373586871825,Proteoglycans in cancer
hsa04140,1.1916206407853105e-26,"1% O2, CyA+ vs 1% O2, CyA-",25.923861982713184,Autophagy - animal
hsa00010,0.39150014376549624,"1% O2, CyA+ vs 1% O2, CyA-",0.4072680741257051,Glycolysis / Gluconeogenesis
hsa04144,2.6214396031744546e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.58146014379051,Endocytosis
hsa01521,0.004359800965696048,"1% O2, CyA+ vs 1% O2, CyA-",2.3605333367573222,EGFR tyrosine kinase inhibitor resistance
hsa05415,0.054289540523506596,"1% O2, CyA+ vs 1% O2, CyA-",1.2652838339558523,Diabetic cardiomyopathy
hsa05133,2.1322762712440625e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.671156526050914,Pertussis
hsa04620,0.09111143927984039,"1% O2, CyA+ vs 1% O2, CyA-",1.0404270927940176,Toll-like receptor signaling pathway
hsa00980,0.3759883747619681,"1% O2, CyA+ vs 1% O2, CyA-",0.42482558287760275,Metabolism of xenobiotics by cytochrome P450
hsa01524,9.46097144192141e-09,"1% O2, CyA+ vs 1% O2, CyA-",8.02406426843906,Platinum drug resistance
hsa00630,0.369610741647378,"1% O2, CyA+ vs 1% O2, CyA-",0.432255415778786,Glyoxylate and dicarboxylate metabolism
hsa05022,0.04686749827971031,"1% O2, CyA+ vs 1% O2, CyA-",1.3291282278818386,Pathways of neurodegeneration - multiple diseases
hsa05165,0.10850007452560073,"1% O2, CyA+ vs 1% O2, CyA-",0.9645699635108799,Human papillomavirus infection
hsa04330,1.925493191933291e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.715458012596187,Notch signaling pathway
hsa04927,0.006851663082090121,"1% O2, CyA+ vs 1% O2, CyA-",2.16420400081257,Cortisol synthesis and secretion
hsa01523,1.7845568562510723e-09,"1% O2, CyA+ vs 1% O2, CyA-",8.748469610800084,Antifolate resistance
hsa05323,0.47975354771623496,"1% O2, CyA+ vs 1% O2, CyA-",0.3189818050283692,Rheumatoid arthritis
hsa00563,0.5205624100602436,"1% O2, CyA+ vs 1% O2, CyA-",0.2835271956059935,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
hsa04917,1.473899485094435e-15,"1% O2, CyA+ vs 1% O2, CyA-",14.831532132865908,Prolactin signaling pathway
hsa05135,5.229460139635347e-08,"1% O2, CyA+ vs 1% O2, CyA-",7.281543142964282,Yersinia infection
hsa04612,0.001213392151622377,"1% O2, CyA+ vs 1% O2, CyA-",2.9159988184558547,Antigen processing and presentation
hsa00330,0.4938898729179278,"1% O2, CyA+ vs 1% O2, CyA-",0.30636987884139316,Arginine and proline metabolism
hsa05016,0.033649244265901004,"1% O2, CyA+ vs 1% O2, CyA-",1.4730246852240942,Huntington disease
hsa04141,2.5202955894341513e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.598548520594706,Protein processing in endoplasmic reticulum
hsa04979,0.2742486803471672,"1% O2, CyA+ vs 1% O2, CyA-",0.5618554535228855,Cholesterol metabolism
hsa00670,0.35909416732229527,"1% O2, CyA+ vs 1% O2, CyA-",0.44479164895444495,One carbon pool by folate
hsa00260,0.44257817702574465,"1% O2, CyA+ vs 1% O2, CyA-",0.35401000439646574,"Glycine, serine and threonine metabolism"
hsa04730,5.610695556394189e-31,"1% O2, CyA+ vs 1% O2, CyA-",30.25098329603815,Long-term depression
hsa04650,0.039328114392634984,"1% O2, CyA+ vs 1% O2, CyA-",1.405296875571053,Natural killer cell mediated cytotoxicity
hsa04720,1.517438502826187e-39,"1% O2, CyA+ vs 1% O2, CyA-",38.81888890053239,Long-term potentiation
hsa00360,0.5347690698645875,"1% O2, CyA+ vs 1% O2, CyA-",0.2718337195394315,Phenylalanine metabolism
hsa05020,4.0193699020351145e-16,"1% O2, CyA+ vs 1% O2, CyA-",15.395842023909896,Prion disease
hsa00760,0.35713092803075586,"1% O2, CyA+ vs 1% O2, CyA-",0.4471725376776542,Nicotinate and nicotinamide metabolism
hsa05210,0.010079503187158207,"1% O2, CyA+ vs 1% O2, CyA-",1.996560873485043,Colorectal cancer
hsa03018,0.05599402406712156,"1% O2, CyA+ vs 1% O2, CyA-",1.2518583203716602,RNA degradation
hsa00410,0.3728395795948416,"1% O2, CyA+ vs 1% O2, CyA-",0.4284779903973884,beta-Alanine metabolism
hsa00565,0.43564622320511487,"1% O2, CyA+ vs 1% O2, CyA-",0.36086604668967404,Ether lipid metabolism
hsa04350,0.2180045053108357,"1% O2, CyA+ vs 1% O2, CyA-",0.6615345311136656,TGF-beta signaling pathway
hsa05150,0.16428925017117785,"1% O2, CyA+ vs 1% O2, CyA-",0.7843908525361735,Staphylococcus aureus infection
hsa00120,0.5339556644061566,"1% O2, CyA+ vs 1% O2, CyA-",0.27249480196604586,Primary bile acid biosynthesis
hsa04810,0.00014098186590606314,"1% O2, CyA+ vs 1% O2, CyA-",3.850836745808544,Regulation of actin cytoskeleton
hsa05144,0.4648814814979504,"1% O2, CyA+ vs 1% O2, CyA-",0.3326577535446755,Malaria
hsa04072,0.06214610474845009,"1% O2, CyA+ vs 1% O2, CyA-",1.2065860872841094,Phospholipase D signaling pathway
hsa00910,1.8998276204847694e-41,"1% O2, CyA+ vs 1% O2, CyA-",40.721285802662166,Nitrogen metabolism
hsa00513,0.08249954529641323,"1% O2, CyA+ vs 1% O2, CyA-",1.0835484450961699,Various types of N-glycan biosynthesis
hsa05134,0.03825520913674648,"1% O2, CyA+ vs 1% O2, CyA-",1.41730941945648,Legionellosis
hsa04970,0.2557365332915711,"1% O2, CyA+ vs 1% O2, CyA-",0.5922072263201796,Salivary secretion
hsa05171,0.11571482421967288,"1% O2, CyA+ vs 1% O2, CyA-",0.9366110000422521,Coronavirus disease - COVID-19
hsa05017,0.0010349256053036606,"1% O2, CyA+ vs 1% O2, CyA-",2.9850908679532804,Spinocerebellar ataxia
hsa04976,9.731038611763603e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.011840804203847,Bile secretion
hsa04060,0.27000875239604516,"1% O2, CyA+ vs 1% O2, CyA-",0.5686221578569455,Cytokine-cytokine receptor interaction
hsa04925,0.0001929337399409309,"1% O2, CyA+ vs 1% O2, CyA-",3.7145918169966614,Aldosterone synthesis and secretion
hsa00280,0.08147997482795077,"1% O2, CyA+ vs 1% O2, CyA-",1.0889491138407954,"Valine, leucine and isoleucine degradation"
hsa00380,0.26733363357864554,"1% O2, CyA+ vs 1% O2, CyA-",0.5729463986743677,Tryptophan metabolism
hsa04662,0.00039107835472947973,"1% O2, CyA+ vs 1% O2, CyA-",3.407736220564584,B cell receptor signaling pathway
hsa00970,0.03906968844094294,"1% O2, CyA+ vs 1% O2, CyA-",1.4081600520185933,Aminoacyl-tRNA biosynthesis
hsa04936,0.0010606097831783673,"1% O2, CyA+ vs 1% O2, CyA-",2.9744443712201107,Alcoholic liver disease
hsa04923,0.12586318064614116,"1% O2, CyA+ vs 1% O2, CyA-",0.9001012975399538,Regulation of lipolysis in adipocytes
hsa05215,2.6918296608515354e-19,"1% O2, CyA+ vs 1% O2, CyA-",18.569952425760402,Prostate cancer
hsa05224,4.052154887463177e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.392313962747845,Breast cancer
hsa04014,3.1008256484191706e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.508522652356094,Ras signaling pathway
hsa04151,0.06077763901617038,"1% O2, CyA+ vs 1% O2, CyA-",1.2162561746437783,PI3K-Akt signaling pathway
hsa05417,0.016661120941735223,"1% O2, CyA+ vs 1% O2, CyA-",1.77829578309529,Lipid and atherosclerosis
hsa04210,0.01852099970053193,"1% O2, CyA+ vs 1% O2, CyA-",1.7323355752832958,Apoptosis
hsa04713,0.30981543707311754,"1% O2, CyA+ vs 1% O2, CyA-",0.5088969465876455,Circadian entrainment
hsa05120,0.00967609637232,"1% O2, CyA+ vs 1% O2, CyA-",2.0142998147873845,Epithelial cell signaling in Helicobacter pylori infection
hsa00350,0.4860770793651204,"1% O2, CyA+ vs 1% O2, CyA-",0.3132948573042698,Tyrosine metabolism
hsa05322,0.5213752466173436,"1% O2, CyA+ vs 1% O2, CyA-",0.28284959171906615,Systemic lupus erythematosus
hsa05163,0.16110033889412223,"1% O2, CyA+ vs 1% O2, CyA-",0.7929035459886502,Human cytomegalovirus infection
hsa00030,0.055259226079830304,"1% O2, CyA+ vs 1% O2, CyA-",1.257595201786731,Pentose phosphate pathway
hsa00230,0.2600728484410381,"1% O2, CyA+ vs 1% O2, CyA-",0.584904985703936,Purine metabolism
hsa04211,0.00031638391831643033,"1% O2, CyA+ vs 1% O2, CyA-",3.4997855996494964,Longevity regulating pathway
hsa04611,1.8136416636692953e-10,"1% O2, CyA+ vs 1% O2, CyA-",9.741448515988159,Platelet activation
hsa04012,0.00039513075983069185,"1% O2, CyA+ vs 1% O2, CyA-",3.403259160385001,ErbB signaling pathway
hsa04728,0.44055778052915073,"1% O2, CyA+ vs 1% O2, CyA-",0.35599712443845577,Dopaminergic synapse
hsa05219,0.027039261382263136,"1% O2, CyA+ vs 1% O2, CyA-",1.568005175969624,Bladder cancer
hsa00600,5.798838388799388e-10,"1% O2, CyA+ vs 1% O2, CyA-",9.2366589946887,Sphingolipid metabolism
hsa04972,4.7753671152031095e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.320993235603103,Pancreatic secretion
hsa04360,2.65836085980215e-16,"1% O2, CyA+ vs 1% O2, CyA-",15.575386065987953,Axon guidance
hsa04722,9.271454780206082e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.032852115537778,Neurotrophin signaling pathway
hsa00512,0.5329968120676581,"1% O2, CyA+ vs 1% O2, CyA-",0.2732753885448446,Mucin type O-glycan biosynthesis
hsa04723,0.16403842937486596,"1% O2, CyA+ vs 1% O2, CyA-",0.7850543976209243,Retrograde endocannabinoid signaling
hsa00601,0.5334572172227762,"1% O2, CyA+ vs 1% O2, CyA-",0.27290040486015105,Glycosphingolipid biosynthesis - lacto and neolacto series
hsa05204,0.3339929593170956,"1% O2, CyA+ vs 1% O2, CyA-",0.47626268816437256,Chemical carcinogenesis - DNA adducts
hsa04071,7.809034384930373e-06,"1% O2, CyA+ vs 1% O2, CyA-",5.107402664870853,Sphingolipid signaling pathway
hsa04213,0.0056040932973401136,"1% O2, CyA+ vs 1% O2, CyA-",2.25149464316094,Longevity regulating pathway - multiple species
hsa04270,0.020551383672715782,"1% O2, CyA+ vs 1% O2, CyA-",1.687158932853824,Vascular smooth muscle contraction
hsa04918,3.21008990833264e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.49348280368674,Thyroid hormone synthesis
hsa04657,0.20127528348514334,"1% O2, CyA+ vs 1% O2, CyA-",0.6962095530053716,IL-17 signaling pathway
hsa04622,3.894931799775253e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.4095001424177545,RIG-I-like receptor signaling pathway
hsa00052,0.07362338719317432,"1% O2, CyA+ vs 1% O2, CyA-",1.132984205831689,Galactose metabolism
hsa00515,0.5404162651150017,"1% O2, CyA+ vs 1% O2, CyA-",0.2672715883261913,Mannose type O-glycan biosynthesis
hsa04659,0.1893609826446973,"1% O2, CyA+ vs 1% O2, CyA-",0.7227095014031053,Th17 cell differentiation
hsa00270,0.27878057386961724,"1% O2, CyA+ vs 1% O2, CyA-",0.5547374922496631,Cysteine and methionine metabolism
hsa04915,0.1954784173708774,"1% O2, CyA+ vs 1% O2, CyA-",0.7089011857574181,Estrogen signaling pathway
hsa04216,0.0013504756307258813,"1% O2, CyA+ vs 1% O2, CyA-",2.8695132482308923,Ferroptosis
hsa04512,0.39783736379331514,"1% O2, CyA+ vs 1% O2, CyA-",0.40029443155033784,ECM-receptor interaction
hsa04510,0.29205347199197984,"1% O2, CyA+ vs 1% O2, CyA-",0.5345376264111212,Focal adhesion
hsa04668,0.0009748027330640363,"1% O2, CyA+ vs 1% O2, CyA-",3.011083261849884,TNF signaling pathway
hsa05226,0.005353421905205077,"1% O2, CyA+ vs 1% O2, CyA-",2.2713685283554055,Gastric cancer
hsa00770,0.5180375922919238,"1% O2, CyA+ vs 1% O2, CyA-",0.28563872378263655,Pantothenate and CoA biosynthesis
hsa05131,8.518179420126061e-07,"1% O2, CyA+ vs 1% O2, CyA-",6.069653216533924,Shigellosis
hsa01522,0.3145618702108116,"1% O2, CyA+ vs 1% O2, CyA-",0.5022939217656182,Endocrine resistance
hsa04062,0.031004232771517516,"1% O2, CyA+ vs 1% O2, CyA-",1.5085790112036288,Chemokine signaling pathway
hsa04911,0.14415408589671014,"1% O2, CyA+ vs 1% O2, CyA-",0.84117304347871,Insulin secretion
hsa00040,0.48120064702092663,"1% O2, CyA+ vs 1% O2, CyA-",0.3176737973807606,Pentose and glucuronate interconversions
hsa04930,7.239742968128885e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.140276852242746,Type II diabetes mellitus
hsa05202,1.9078920836848405e-05,"1% O2, CyA+ vs 1% O2, CyA-",4.719446193984985,Transcriptional misregulation in cancer
hsa05145,0.24643779571308233,"1% O2, CyA+ vs 1% O2, CyA-",0.6082926844506383,Toxoplasmosis
hsa04380,0.02098138105115567,"1% O2, CyA+ vs 1% O2, CyA-",1.6781659287661008,Osteoclast differentiation
hsa04010,0.2612649918038715,"1% O2, CyA+ vs 1% O2, CyA-",0.582918779652603,MAPK signaling pathway
hsa05142,0.21499106791234568,"1% O2, CyA+ vs 1% O2, CyA-",0.6675795830470057,Chagas disease
hsa00020,0.26913124693469015,"1% O2, CyA+ vs 1% O2, CyA-",0.5700358764335636,Citrate cycle (TCA cycle)
hsa04744,0.5192823349352365,"1% O2, CyA+ vs 1% O2, CyA-",0.2845964510822766,Phototransduction
hsa04921,0.12996096799726814,"1% O2, CyA+ vs 1% O2, CyA-",0.8861870625293754,Oxytocin signaling pathway
hsa05225,2.860951717100042e-08,"1% O2, CyA- vs 19% O2, CyA-",7.543489471511047,Hepatocellular carcinoma
hsa04962,0.47270760033609216,"1% O2, CyA- vs 19% O2, CyA-",0.3254074149226207,Vasopressin-regulated water reabsorption
hsa03250,0.0,"1% O2, CyA- vs 19% O2, CyA-",inf,Viral life cycle - HIV-1
hsa04912,8.130049206969256e-27,"1% O2, CyA- vs 19% O2, CyA-",26.089906825838828,GnRH signaling pathway
hsa05218,5.743457993613058e-23,"1% O2, CyA- vs 19% O2, CyA-",22.240826550919216,Melanoma
hsa00100,5.055988653220763e-14,"1% O2, CyA- vs 19% O2, CyA-",13.296193909379378,Steroid biosynthesis
hsa00830,0.47411815738381446,"1% O2, CyA- vs 19% O2, CyA-",0.32411341211281847,Retinol metabolism
hsa00785,0.5533572134259467,"1% O2, CyA- vs 19% O2, CyA-",0.2569944243265958,Lipoic acid metabolism
hsa04625,2.4804825302195494e-15,"1% O2, CyA- vs 19% O2, CyA-",14.605463827307887,C-type lectin receptor signaling pathway
hsa05221,0.0007808481112359057,"1% O2, CyA- vs 19% O2, CyA-",3.1074334358631854,Acute myeloid leukemia
hsa04145,4.2388091154894225e-06,"1% O2, CyA- vs 19% O2, CyA-",5.37275614039243,Phagosome
hsa05217,0.4793481307478647,"1% O2, CyA- vs 19% O2, CyA-",0.31934896185162037,Basal cell carcinoma
hsa05223,0.11618817259151315,"1% O2, CyA- vs 19% O2, CyA-",0.9348380788275462,Non-small cell lung cancer
hsa05330,0.5474939395891862,"1% O2, CyA- vs 19% O2, CyA-",0.2616206838258198,Allograft rejection
hsa04022,0.12069933095484481,"1% O2, CyA- vs 19% O2, CyA-",0.9182951372218252,cGMP-PKG signaling pathway
hsa00140,0.5193713631499066,"1% O2, CyA- vs 19% O2, CyA-",0.2845219999682414,Steroid hormone biosynthesis
hsa04066,0.021963800912060946,"1% O2, CyA- vs 19% O2, CyA-",1.6582925015491299,HIF-1 signaling pathway
hsa04724,0.44873807056669135,"1% O2, CyA- vs 19% O2, CyA-",0.34800708371930233,Glutamatergic synapse
hsa05012,0.3260892491194365,"1% O2, CyA- vs 19% O2, CyA-",0.48666351927153684,Parkinson disease
hsa05146,0.46177550225410563,"1% O2, CyA- vs 19% O2, CyA-",0.3355691106524244,Amoebiasis
hsa05410,0.35552169433725844,"1% O2, CyA- vs 19% O2, CyA-",0.44913389298346473,Hypertrophic cardiomyopathy
hsa00510,0.5044386430505045,"1% O2, CyA- vs 19% O2, CyA-",0.2971916512409812,N-Glycan biosynthesis
hsa04114,0.0,"1% O2, CyA- vs 19% O2, CyA-",inf,Oocyte meiosis
hsa04310,0.028037750883001245,"1% O2, CyA- vs 19% O2, CyA-",1.5522568273058794,Wnt signaling pathway
hsa03015,5.1511867055089725e-08,"1% O2, CyA- vs 19% O2, CyA-",7.288092708767684,mRNA surveillance pathway
hsa03440,0.09907101812075803,"1% O2, CyA- vs 19% O2, CyA-",1.0040533738808204,Homologous recombination
hsa05152,0.29703084833156196,"1% O2, CyA- vs 19% O2, CyA-",0.5271984444051492,Tuberculosis
hsa04110,0.021844613291759338,"1% O2, CyA- vs 19% O2, CyA-",1.6606556390634335,Cell cycle
hsa00604,0.5358451613889029,"1% O2, CyA- vs 19% O2, CyA-",0.27096068655561956,Glycosphingolipid biosynthesis - ganglio series
hsa05416,1.5384718636039724e-15,"1% O2, CyA- vs 19% O2, CyA-",14.812910441953587,Viral myocarditis
hsa04664,1.0853179158185263e-08,"1% O2, CyA- vs 19% O2, CyA-",7.9644430278414085,Fc epsilon RI signaling pathway
hsa04929,0.001328925212619113,"1% O2, CyA- vs 19% O2, CyA-",2.8764994589825825,GnRH secretion
hsa04136,2.730487285181987e-28,"1% O2, CyA- vs 19% O2, CyA-",27.563759841464332,Autophagy - other
hsa04660,5.065329016379853e-06,"1% O2, CyA- vs 19% O2, CyA-",5.295392339966594,T cell receptor signaling pathway
hsa00310,0.12497803472579755,"1% O2, CyA- vs 19% O2, CyA-",0.9031663088769014,Lysine degradation
hsa04070,0.2739628478981574,"1% O2, CyA- vs 19% O2, CyA-",0.5623083278613725,Phosphatidylinositol signaling system
hsa04726,0.19602909723035744,"1% O2, CyA- vs 19% O2, CyA-",0.707679460129858,Serotonergic synapse
hsa05332,0.551165837599227,"1% O2, CyA- vs 19% O2, CyA-",0.2587177087381929,Graft-versus-host disease
hsa04916,0.22581462288753562,"1% O2, CyA- vs 19% O2, CyA-",0.6462479382580826,Melanogenesis
hsa05169,0.18006548303180947,"1% O2, CyA- vs 19% O2, CyA-",0.7445695296318914,Epstein-Barr virus infection
hsa00900,0.2494693057571311,"1% O2, CyA- vs 19% O2, CyA-",0.602982881544963,Terpenoid backbone biosynthesis
hsa00591,0.4685671583942502,"1% O2, CyA- vs 19% O2, CyA-",0.32922815412570255,Linoleic acid metabolism
hsa04024,0.0006942789230734023,"1% O2, CyA- vs 19% O2, CyA-",3.158466018859618,cAMP signaling pathway
hsa04068,8.824824671423598e-19,"1% O2, CyA- vs 19% O2, CyA-",18.05429391426758,FoxO signaling pathway
hsa00520,0.378172590316002,"1% O2, CyA- vs 19% O2, CyA-",0.4223099517096276,Amino sugar and nucleotide sugar metabolism
hsa00860,0.49272764388801593,"1% O2, CyA- vs 19% O2, CyA-",0.3073930714753692,Porphyrin metabolism
hsa04922,1.21764116477455e-131,"1% O2, CyA- vs 19% O2, CyA-",130.914480678139,Glucagon signaling pathway
hsa04926,0.08409406170300882,"1% O2, CyA- vs 19% O2, CyA-",1.0752346707974496,Relaxin signaling pathway
hsa04370,0.14249834808310174,"1% O2, CyA- vs 19% O2, CyA-",0.8461901701996942,VEGF signaling pathway
hsa05213,7.182996959953749e-22,"1% O2, CyA- vs 19% O2, CyA-",21.143694317372297,Endometrial cancer
hsa04520,6.930564009592929e-08,"1% O2, CyA- vs 19% O2, CyA-",7.1592314210466625,Adherens junction
hsa05110,0.06969508980839076,"1% O2, CyA- vs 19% O2, CyA-",1.1567978179455785,Vibrio cholerae infection
hsa05220,0.010455475303181257,"1% O2, CyA- vs 19% O2, CyA-",1.9806562194836268,Chronic myeloid leukemia
hsa05235,0.049861318604980005,"1% O2, CyA- vs 19% O2, CyA-",1.3022362405676164,PD-L1 expression and PD-1 checkpoint pathway in cancer
hsa05207,2.4429069821153973e-06,"1% O2, CyA- vs 19% O2, CyA-",5.612093069221032,Chemical carcinogenesis - receptor activation
hsa05418,0.3664883469930376,"1% O2, CyA- vs 19% O2, CyA-",0.43593982980069407,Fluid shear stress and atherosclerosis
hsa00920,0.5243552110537727,"1% O2, CyA- vs 19% O2, CyA-",0.2803744116099534,Sulfur metabolism
hsa04931,0.11353916646580203,"1% O2, CyA- vs 19% O2, CyA-",0.9448542984198488,Insulin resistance
hsa00500,0.3454988584831547,"1% O2, CyA- vs 19% O2, CyA-",0.4615533831820719,Starch and sucrose metabolism
hsa05216,0.3889991512868677,"1% O2, CyA- vs 19% O2, CyA-",0.4100513462111359,Thyroid cancer
hsa00740,0.47425765650697166,"1% O2, CyA- vs 19% O2, CyA-",0.323985649048921,Riboflavin metabolism
hsa00062,0.3394919602367694,"1% O2, CyA- vs 19% O2, CyA-",0.4691705061144086,Fatty acid elongation
hsa04390,0.3689171040632998,"1% O2, CyA- vs 19% O2, CyA-",0.43307120915891045,Hippo signaling pathway
hsa04064,0.17256369187378168,"1% O2, CyA- vs 19% O2, CyA-",0.7630505763938066,NF-kappa B signaling pathway
hsa04932,0.0009609116547358893,"1% O2, CyA- vs 19% O2, CyA-",3.017316539099824,Non-alcoholic fatty liver disease
hsa05222,1.0535800093226905e-11,"1% O2, CyA- vs 19% O2, CyA-",10.977332478292295,Small cell lung cancer
hsa05320,0.5313261079848132,"1% O2, CyA- vs 19% O2, CyA-",0.2746388434631974,Autoimmune thyroid disease
hsa04115,0.3554224923779447,"1% O2, CyA- vs 19% O2, CyA-",0.44925509198785524,p53 signaling pathway
hsa04710,1.9058048467445354e-57,"1% O2, CyA- vs 19% O2, CyA-",56.71992157291133,Circadian rhythm
hsa05206,5.416223451867332e-07,"1% O2, CyA- vs 19% O2, CyA-",6.266303426687923,MicroRNAs in cancer
hsa05032,0.32209533094694054,"1% O2, CyA- vs 19% O2, CyA-",0.49201557061239903,Morphine addiction
hsa00620,0.21584760438988487,"1% O2, CyA- vs 19% O2, CyA-",0.6658527670495356,Pyruvate metabolism
hsa05132,2.544027649918631e-30,"1% O2, CyA- vs 19% O2, CyA-",29.594478172842088,Salmonella infection
hsa04658,0.3326714486533333,"1% O2, CyA- vs 19% O2, CyA-",0.477984470620181,Th1 and Th2 cell differentiation
hsa05014,2.8598203591981947e-06,"1% O2, CyA- vs 19% O2, CyA-",5.5436612464021575,Amyotrophic lateral sclerosis
hsa04933,0.3015388245678432,"1% O2, CyA- vs 19% O2, CyA-",0.5206567624291576,AGE-RAGE signaling pathway in diabetic complications
hsa00531,0.5190645743853592,"1% O2, CyA- vs 19% O2, CyA-",0.2847786102541785,Glycosaminoglycan degradation
hsa04714,0.018258399409371608,"1% O2, CyA- vs 19% O2, CyA-",1.7385372967987287,Thermogenesis
hsa00592,0.4321129995812536,"1% O2, CyA- vs 19% O2, CyA-",0.3644026682838092,alpha-Linolenic acid metabolism
hsa05170,0.2245607978294316,"1% O2, CyA- vs 19% O2, CyA-",0.6486660573904318,Human immunodeficiency virus 1 infection
hsa05160,0.19768509577574533,"1% O2, CyA- vs 19% O2, CyA-",0.704026072549504,Hepatitis C
hsa04392,0.4455551974108475,"1% O2, CyA- vs 19% O2, CyA-",0.3510984859121592,Hippo signaling pathway - multiple species
hsa04666,6.583553336261267e-05,"1% O2, CyA- vs 19% O2, CyA-",4.181539641674477,Fc gamma R-mediated phagocytosis
hsa04920,0.027873187133582167,"1% O2, CyA- vs 19% O2, CyA-",1.5548133694499582,Adipocytokine signaling pathway
hsa04940,0.5294056759233395,"1% O2, CyA- vs 19% O2, CyA-",0.27621140680314077,Type I diabetes mellitus
hsa04672,0.18979638514806035,"1% O2, CyA- vs 19% O2, CyA-",0.7217120633797504,Intestinal immune network for IgA production
hsa00780,0.544107571241728,"1% O2, CyA- vs 19% O2, CyA-",0.26431523085640696,Biotin metabolism
hsa00590,0.48923377313055905,"1% O2, CyA- vs 19% O2, CyA-",0.31048357007819144,Arachidonic acid metabolism
hsa05161,0.3404619003427053,"1% O2, CyA- vs 19% O2, CyA-",0.46793148109837346,Hepatitis B
hsa04540,0.3221826777222073,"1% O2, CyA- vs 19% O2, CyA-",0.4918978133019449,Gap junction
hsa04913,0.00025425491650874984,"1% O2, CyA- vs 19% O2, CyA-",3.5947306404033457,Ovarian steroidogenesis
hsa05212,0.08078857538075301,"1% O2, CyA- vs 19% O2, CyA-",1.0926500501153036,Pancreatic cancer
hsa05211,3.5218491912607744e-40,"1% O2, CyA- vs 19% O2, CyA-",39.45322924484959,Renal cell carcinoma
hsa04371,0.003995327629519282,"1% O2, CyA- vs 19% O2, CyA-",2.3984476013667226,Apelin signaling pathway
hsa05164,0.04337247749043619,"1% O2, CyA- vs 19% O2, CyA-",1.3627857696959529,Influenza A
hsa04146,0.3608786208890561,"1% O2, CyA- vs 19% O2, CyA-",0.442638845579536,Peroxisome
hsa04122,1.7882935958837105e-08,"1% O2, CyA- vs 19% O2, CyA-",7.747561178714152,Sulfur relay system
hsa05167,0.03577622548442194,"1% O2, CyA- vs 19% O2, CyA-",1.446405480922299,Kaposi sarcoma-associated herpesvirus infection
hsa00562,0.05321007257181452,"1% O2, CyA- vs 19% O2, CyA-",1.2740061487520846,Inositol phosphate metabolism
hsa04935,0.173740876547049,"1% O2, CyA- vs 19% O2, CyA-",0.7600979917410348,"Growth hormone synthesis, secretion and action"
hsa00240,0.17899190802781118,"1% O2, CyA- vs 19% O2, CyA-",0.7471666024184664,Pyrimidine metabolism
hsa05200,0.08353881841269584,"1% O2, CyA- vs 19% O2, CyA-",1.078111671762724,Pathways in cancer
hsa00480,0.48041634207543976,"1% O2, CyA- vs 19% O2, CyA-",0.3183822278459991,Glutathione metabolism
hsa04150,8.484682527052306e-20,"1% O2, CyA- vs 19% O2, CyA-",19.07136440311988,mTOR signaling pathway
hsa05034,5.52323815051552e-15,"1% O2, CyA- vs 19% O2, CyA-",14.257806230499854,Alcoholism
hsa04750,0.23946079022902056,"1% O2, CyA- vs 19% O2, CyA-",0.6207655886429203,Inflammatory mediator regulation of TRP channels
hsa04137,0.0013932466337654421,"1% O2, CyA- vs 19% O2, CyA-",2.855971997572935,Mitophagy - animal
hsa05203,1.0851929202070656e-06,"1% O2, CyA- vs 19% O2, CyA-",5.964493048236127,Viral carcinogenesis
hsa03320,0.4850347057820748,"1% O2, CyA- vs 19% O2, CyA-",0.31422718512889397,PPAR signaling pathway
hsa00564,0.4504314643856793,"1% O2, CyA- vs 19% O2, CyA-",0.3463712799422432,Glycerophospholipid metabolism
hsa04961,0.48962326710123155,"1% O2, CyA- vs 19% O2, CyA-",0.310137952517766,Endocrine and other factor-regulated calcium reabsorption
hsa00220,0.43505272542150997,"1% O2, CyA- vs 19% O2, CyA-",0.361458106328123,Arginine biosynthesis
hsa05168,0.20420490181158435,"1% O2, CyA- vs 19% O2, CyA-",0.6899338371552222,Herpes simplex virus 1 infection
hsa04061,0.00012046521861015497,"1% O2, CyA- vs 19% O2, CyA-",3.9191383269158804,Viral protein interaction with cytokine and cytokine receptor
hsa05412,0.1732720978857848,"1% O2, CyA- vs 19% O2, CyA-",0.7612713663677212,Arrhythmogenic right ventricular cardiomyopathy
hsa04924,0.41670749541013385,"1% O2, CyA- vs 19% O2, CyA-",0.3801686877213051,Renin secretion
hsa05143,0.48205794657588497,"1% O2, CyA- vs 19% O2, CyA-",0.31690075353389247,African trypanosomiasis
hsa04960,0.18412760223421465,"1% O2, CyA- vs 19% O2, CyA-",0.7348811023191754,Aldosterone-regulated sodium reabsorption
hsa05162,0.1343064688785761,"1% O2, CyA- vs 19% O2, CyA-",0.8719030690095333,Measles
hsa00730,0.5023075402991356,"1% O2, CyA- vs 19% O2, CyA-",0.2990303024581542,Thiamine metabolism
hsa05030,0.19615199905358394,"1% O2, CyA- vs 19% O2, CyA-",0.7074072614650262,Cocaine addiction
hsa00750,0.5024428740304142,"1% O2, CyA- vs 19% O2, CyA-",0.2989133088401833,Vitamin B6 metabolism
hsa04623,0.014691371271761833,"1% O2, CyA- vs 19% O2, CyA-",1.8329376658867171,Cytosolic DNA-sensing pathway
hsa00650,0.27902170014352984,"1% O2, CyA- vs 19% O2, CyA-",0.5543620193568348,Butanoate metabolism
hsa05010,0.012377907426802696,"1% O2, CyA- vs 19% O2, CyA-",1.907352769678356,Alzheimer disease
hsa05031,6.949199982938069e-06,"1% O2, CyA- vs 19% O2, CyA-",5.158065190085297,Amphetamine addiction
hsa00071,0.06392491122813515,"1% O2, CyA- vs 19% O2, CyA-",1.1943298664014756,Fatty acid degradation
hsa00561,0.4755690275778288,"1% O2, CyA- vs 19% O2, CyA-",0.32278643746387536,Glycerolipid metabolism
hsa04614,0.4839520942530546,"1% O2, CyA- vs 19% O2, CyA-",0.3151976264366927,Renin-angiotensin system
hsa04971,0.054495400994809096,"1% O2, CyA- vs 19% O2, CyA-",1.2636401473904006,Gastric acid secretion
hsa04215,3.796630406988209e-14,"1% O2, CyA- vs 19% O2, CyA-",13.420601678345601,Apoptosis - multiple species
hsa04080,0.36543919815473014,"1% O2, CyA- vs 19% O2, CyA-",0.4371848706964855,Neuroactive ligand-receptor interaction
hsa05231,0.030572520714512906,"1% O2, CyA- vs 19% O2, CyA-",1.5146687520730069,Choline metabolism in cancer
hsa05166,0.0038815587665948672,"1% O2, CyA- vs 19% O2, CyA-",2.4109938342552546,Human T-cell leukemia virus 1 infection
hsa00790,0.4207299627399032,"1% O2, CyA- vs 19% O2, CyA-",0.3759965581298147,Folate biosynthesis
hsa00983,0.38353607532496814,"1% O2, CyA- vs 19% O2, CyA-",0.41619378014339337,Drug metabolism - other enzymes
hsa04721,0.10583794791191087,"1% O2, CyA- vs 19% O2, CyA-",0.9753585892587003,Synaptic vesicle cycle
hsa04218,1.3970415166004713e-166,"1% O2, CyA- vs 19% O2, CyA-",165.85479068754182,Cellular senescence
hsa04530,0.005123337340994898,"1% O2, CyA- vs 19% O2, CyA-",2.290447047498781,Tight junction
hsa04340,0.2274901697851438,"1% O2, CyA- vs 19% O2, CyA-",0.6430373651620613,Hedgehog signaling pathway
hsa04725,8.791287109211397e-10,"1% O2, CyA- vs 19% O2, CyA-",9.055947536358946,Cholinergic synapse
hsa04740,0.5219149701144177,"1% O2, CyA- vs 19% O2, CyA-",0.28240024607451925,Olfactory transduction
hsa04152,1.0110057198660936e-22,"1% O2, CyA- vs 19% O2, CyA-",21.99524638733753,AMPK signaling pathway
hsa03460,0.0006122510964672979,"1% O2, CyA- vs 19% O2, CyA-",3.213070428433921,Fanconi anemia pathway
hsa05214,0.0057629030441995925,"1% O2, CyA- vs 19% O2, CyA-",2.239358686981773,Glioma
hsa00440,0.5357689231817742,"1% O2, CyA- vs 19% O2, CyA-",0.2710224808772859,Phosphonate and phosphinate metabolism
hsa04020,0.4390008106679098,"1% O2, CyA- vs 19% O2, CyA-",0.3575346777800317,Calcium signaling pathway
hsa04514,0.055960755582789484,"1% O2, CyA- vs 19% O2, CyA-",1.252116430291347,Cell adhesion molecules
hsa04613,0.023914085191031897,"1% O2, CyA- vs 19% O2, CyA-",1.6213462279672557,Neutrophil extracellular trap formation
hsa00250,0.4210237922098735,"1% O2, CyA- vs 19% O2, CyA-",0.37569336132941733,"Alanine, aspartate and glutamate metabolism"
hsa04217,0.01658708863671134,"1% O2, CyA- vs 19% O2, CyA-",1.7802298345884948,Necroptosis
hsa04934,3.0065485923381266e-16,"1% O2, CyA- vs 19% O2, CyA-",15.52193177262215,Cushing syndrome
hsa05140,1.301689599131083e-08,"1% O2, CyA- vs 19% O2, CyA-",7.885492565273292,Leishmaniasis
hsa04919,2.946731652548414e-07,"1% O2, CyA- vs 19% O2, CyA-",6.530659411867687,Thyroid hormone signaling pathway
hsa04550,0.014193664007238042,"1% O2, CyA- vs 19% O2, CyA-",1.847905479615063,Signaling pathways regulating pluripotency of stem cells
hsa00061,0.005698544100240483,"1% O2, CyA- vs 19% O2, CyA-",2.244236086431981,Fatty acid biosynthesis
hsa00532,0.5150911982966484,"1% O2, CyA- vs 19% O2, CyA-",0.2881158711325366,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
hsa04742,0.3118999954397339,"1% O2, CyA- vs 19% O2, CyA-",0.5059846315926427,Taste transduction
hsa04261,0.22131814106742442,"1% O2, CyA- vs 19% O2, CyA-",0.6549829862418645,Adrenergic signaling in cardiomyocytes
hsa04910,0.1193457417785207,"1% O2, CyA- vs 19% O2, CyA-",0.923193071882048,Insulin signaling pathway
hsa04015,1.6643340708551383e-08,"1% O2, CyA- vs 19% O2, CyA-",7.778759496214175,Rap1 signaling pathway
hsa05208,0.034653195665394584,"1% O2, CyA- vs 19% O2, CyA-",1.4602567092238414,Chemical carcinogenesis - reactive oxygen species
hsa04914,1.8388882535118232e-159,"1% O2, CyA- vs 19% O2, CyA-",158.73544466138603,Progesterone-mediated oocyte maturation
hsa04130,0.2316098475745516,"1% O2, CyA- vs 19% O2, CyA-",0.6352429792435333,SNARE interactions in vesicular transport
hsa00640,4.559241141021499e-20,"1% O2, CyA- vs 19% O2, CyA-",19.341107437092745,Propanoate metabolism
hsa00450,0.4509789499786137,"1% O2, CyA- vs 19% O2, CyA-",0.3458437289013828,Selenocompound metabolism
hsa04621,1.132964451612523e-06,"1% O2, CyA- vs 19% O2, CyA-",5.94578371653618,NOD-like receptor signaling pathway
hsa05130,0.0008986669449953825,"1% O2, CyA- vs 19% O2, CyA-",3.0464012323497704,Pathogenic Escherichia coli infection
hsa04670,0.21514013617471572,"1% O2, CyA- vs 19% O2, CyA-",0.6672785608205271,Leukocyte transendothelial migration
hsa04928,1.4093821365061868e-10,"1% O2, CyA- vs 19% O2, CyA-",9.850971237355534,"Parathyroid hormone synthesis, secretion and action"
hsa00130,0.40862288182728246,"1% O2, CyA- vs 19% O2, CyA-",0.38867731765197155,Ubiquinone and other terpenoid-quinone biosynthesis
hsa05100,0.06580995603624706,"1% O2, CyA- vs 19% O2, CyA-",1.181708399326454,Bacterial invasion of epithelial cells
hsa05414,0.32901452713086987,"1% O2, CyA- vs 19% O2, CyA-",0.48278492602118267,Dilated cardiomyopathy
hsa05321,0.4911189212840595,"1% O2, CyA- vs 19% O2, CyA-",0.3088133335308683,Inflammatory bowel disease
hsa00051,0.3386999691673621,"1% O2, CyA- vs 19% O2, CyA-",0.47018484289019435,Fructose and mannose metabolism
hsa05230,4.2798967964038807e-17,"1% O2, CyA- vs 19% O2, CyA-",16.368566703251478,Central carbon metabolism in cancer
hsa04727,0.0031316483268910462,"1% O2, CyA- vs 19% O2, CyA-",2.504227013621066,GABAergic synapse
hsa04630,0.38304598152400915,"1% O2, CyA- vs 19% O2, CyA-",0.41674908941646827,JAK-STAT signaling pathway
hsa00603,0.523248130002113,"1% O2, CyA- vs 19% O2, CyA-",0.28129231507950947,Glycosphingolipid biosynthesis - globo and isoglobo series
hsa00340,0.5198929379317256,"1% O2, CyA- vs 19% O2, CyA-",0.28408608185111567,Histidine metabolism
hsa04610,0.35089612889865907,"1% O2, CyA- vs 19% O2, CyA-",0.45482142291376093,Complement and coagulation cascades
hsa05205,0.07879739843336209,"1% O2, CyA- vs 19% O2, CyA-",1.1034881208947898,Proteoglycans in cancer
hsa04140,1.247485403548965e-52,"1% O2, CyA- vs 19% O2, CyA-",51.90396452722379,Autophagy - animal
hsa00010,0.4444671222874033,"1% O2, CyA- vs 19% O2, CyA-",0.3521603587370687,Glycolysis / Gluconeogenesis
hsa04144,5.476581114769991e-07,"1% O2, CyA- vs 19% O2, CyA-",6.261490475522004,Endocytosis
hsa01521,0.0,"1% O2, CyA- vs 19% O2, CyA-",inf,EGFR tyrosine kinase inhibitor resistance
hsa05415,0.23089969963822515,"1% O2, CyA- vs 19% O2, CyA-",0.6365766320267224,Diabetic cardiomyopathy
hsa05133,0.3098460312914546,"1% O2, CyA- vs 19% O2, CyA-",0.5088540622035389,Pertussis
hsa04620,0.10414074739048518,"1% O2, CyA- vs 19% O2, CyA-",0.9823793098329902,Toll-like receptor signaling pathway
hsa00980,0.48592696530577,"1% O2, CyA- vs 19% O2, CyA-",0.31342900017848463,Metabolism of xenobiotics by cytochrome P450
hsa01524,1.858520813352311e-12,"1% O2, CyA- vs 19% O2, CyA-",11.73083257092906,Platinum drug resistance
hsa00630,0.4231599660768696,"1% O2, CyA- vs 19% O2, CyA-",0.3734954263564292,Glyoxylate and dicarboxylate metabolism
hsa05022,0.06972012252536416,"1% O2, CyA- vs 19% O2, CyA-",1.1566418583371048,Pathways of neurodegeneration - multiple diseases
hsa05165,0.3801874266962998,"1% O2, CyA- vs 19% O2, CyA-",0.4200022499290411,Human papillomavirus infection
hsa04330,0.05630274388694894,"1% O2, CyA- vs 19% O2, CyA-",1.2494704395017078,Notch signaling pathway
hsa04927,0.02628679957397901,"1% O2, CyA- vs 19% O2, CyA-",1.5802622861632936,Cortisol synthesis and secretion
hsa01523,0.19240673853780754,"1% O2, CyA- vs 19% O2, CyA-",0.7157797220147408,Antifolate resistance
hsa05323,0.5050256158346647,"1% O2, CyA- vs 19% O2, CyA-",0.2966865931021232,Rheumatoid arthritis
hsa00563,0.5188950683847694,"1% O2, CyA- vs 19% O2, CyA-",0.28492045685076417,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
hsa04917,0.06834040706505548,"1% O2, CyA- vs 19% O2, CyA-",1.1653224386835705,Prolactin signaling pathway
hsa05135,0.23786668913354764,"1% O2, CyA- vs 19% O2, CyA-",0.6236663723318006,Yersinia infection
hsa04612,0.17222912087799913,"1% O2, CyA- vs 19% O2, CyA-",0.7638934152089112,Antigen processing and presentation
hsa00330,0.4740689392777835,"1% O2, CyA- vs 19% O2, CyA-",0.32415849847173106,Arginine and proline metabolism
hsa05016,4.319807969211265e-13,"1% O2, CyA- vs 19% O2, CyA-",12.36453555868637,Huntington disease
hsa04141,2.0033660610090866e-18,"1% O2, CyA- vs 19% O2, CyA-",17.698239687875216,Protein processing in endoplasmic reticulum
hsa04979,0.035894024223479364,"1% O2, CyA- vs 19% O2, CyA-",1.4449778484353129,Cholesterol metabolism
hsa00670,0.37403566000443567,"1% O2, CyA- vs 19% O2, CyA-",0.4270869908346094,One carbon pool by folate
hsa00260,0.5048416930225854,"1% O2, CyA- vs 19% O2, CyA-",0.29684478549544996,"Glycine, serine and threonine metabolism"
hsa04730,0.0,"1% O2, CyA- vs 19% O2, CyA-",inf,Long-term depression
hsa04650,2.4615397333440046e-19,"1% O2, CyA- vs 19% O2, CyA-",18.608793149599624,Natural killer cell mediated cytotoxicity
hsa04720,1.8741556965071714e-10,"1% O2, CyA- vs 19% O2, CyA-",9.727194332698437,Long-term potentiation
hsa00360,0.5360228124092331,"1% O2, CyA- vs 19% O2, CyA-",0.2708167269254667,Phenylalanine metabolism
hsa05020,1.053973779662939e-06,"1% O2, CyA- vs 19% O2, CyA-",5.977170193193057,Prion disease
hsa00760,0.4712285878730983,"1% O2, CyA- vs 19% O2, CyA-",0.3267683702181469,Nicotinate and nicotinamide metabolism
hsa05210,0.09117615131417611,"1% O2, CyA- vs 19% O2, CyA-",1.0401187439863586,Colorectal cancer
hsa03018,0.02821021140353977,"1% O2, CyA- vs 19% O2, CyA-",1.5495936592878536,RNA degradation
hsa00410,0.44466752054697095,"1% O2, CyA- vs 19% O2, CyA-",0.35196459117702966,beta-Alanine metabolism
hsa00565,0.501958086534768,"1% O2, CyA- vs 19% O2, CyA-",0.299332544900025,Ether lipid metabolism
hsa04350,0.04090517771698843,"1% O2, CyA- vs 19% O2, CyA-",1.3882217161590327,TGF-beta signaling pathway
hsa05150,0.43108985837621333,"1% O2, CyA- vs 19% O2, CyA-",0.36543219404023447,Staphylococcus aureus infection
hsa00120,0.531315006670788,"1% O2, CyA- vs 19% O2, CyA-",0.27464791753224416,Primary bile acid biosynthesis
hsa04810,8.359011158415128e-99,"1% O2, CyA- vs 19% O2, CyA-",98.07784509503036,Regulation of actin cytoskeleton
hsa05144,0.4833832654701903,"1% O2, CyA- vs 19% O2, CyA-",0.3157083887644354,Malaria
hsa04072,4.475403632311628e-21,"1% O2, CyA- vs 19% O2, CyA-",20.349167789983696,Phospholipase D signaling pathway
hsa00910,1.8004247568521786e-18,"1% O2, CyA- vs 19% O2, CyA-",17.744625023899317,Nitrogen metabolism
hsa00513,0.36156722815083897,"1% O2, CyA- vs 19% O2, CyA-",0.44181094013872063,Various types of N-glycan biosynthesis
hsa05134,0.35735355812452674,"1% O2, CyA- vs 19% O2, CyA-",0.44690188932563824,Legionellosis
hsa04970,0.09324527091391821,"1% O2, CyA- vs 19% O2, CyA-",1.0303731849141295,Salivary secretion
hsa05171,0.22959471001044962,"1% O2, CyA- vs 19% O2, CyA-",0.6390381225446986,Coronavirus disease - COVID-19
hsa05017,0.13512564641940694,"1% O2, CyA- vs 19% O2, CyA-",0.8692622154385597,Spinocerebellar ataxia
hsa04976,0.03642060724000464,"1% O2, CyA- vs 19% O2, CyA-",1.4386528174981366,Bile secretion
hsa04060,0.03439491632718175,"1% O2, CyA- vs 19% O2, CyA-",1.463505742725136,Cytokine-cytokine receptor interaction
hsa04925,2.524089015710731e-14,"1% O2, CyA- vs 19% O2, CyA-",13.597895333124304,Aldosterone synthesis and secretion
hsa00280,1.9888508343082502e-28,"1% O2, CyA- vs 19% O2, CyA-",27.70139778815063,"Valine, leucine and isoleucine degradation"
hsa00380,0.34859001846188553,"1% O2, CyA- vs 19% O2, CyA-",0.4576850526505427,Tryptophan metabolism
hsa04662,0.038214837624101564,"1% O2, CyA- vs 19% O2, CyA-",1.4177679814043116,B cell receptor signaling pathway
hsa00970,0.236094248392488,"1% O2, CyA- vs 19% O2, CyA-",0.6269145928527871,Aminoacyl-tRNA biosynthesis
hsa04936,0.25324861567604845,"1% O2, CyA- vs 19% O2, CyA-",0.5964529199297609,Alcoholic liver disease
hsa04923,0.455559506117365,"1% O2, CyA- vs 19% O2, CyA-",0.34145488654939543,Regulation of lipolysis in adipocytes
hsa05215,0.11411087578741802,"1% O2, CyA- vs 19% O2, CyA-",0.94267296145936,Prostate cancer
hsa05224,0.27049234340990314,"1% O2, CyA- vs 19% O2, CyA-",0.5678450235773407,Breast cancer
hsa04014,2.7504450171216897e-07,"1% O2, CyA- vs 19% O2, CyA-",6.560597032408206,Ras signaling pathway
hsa04151,1.8566298117444977e-05,"1% O2, CyA- vs 19% O2, CyA-",4.731274680397742,PI3K-Akt signaling pathway
hsa05417,0.14239320265123184,"1% O2, CyA- vs 19% O2, CyA-",0.8465107418896168,Lipid and atherosclerosis
hsa04210,0.0039485681132930385,"1% O2, CyA- vs 19% O2, CyA-",2.4035603659522553,Apoptosis
hsa04713,2.4681158327121893e-15,"1% O2, CyA- vs 19% O2, CyA-",14.607634462010251,Circadian entrainment
hsa05120,0.26067431428179577,"1% O2, CyA- vs 19% O2, CyA-",0.5839017602212093,Epithelial cell signaling in Helicobacter pylori infection
hsa00350,0.48383366410445827,"1% O2, CyA- vs 19% O2, CyA-",0.31530391764802523,Tyrosine metabolism
hsa05322,0.5290942852200566,"1% O2, CyA- vs 19% O2, CyA-",0.27646692928404265,Systemic lupus erythematosus
hsa05163,0.05014748464467254,"1% O2, CyA- vs 19% O2, CyA-",1.2997508459403795,Human cytomegalovirus infection
hsa00030,3.0226299317232246e-05,"1% O2, CyA- vs 19% O2, CyA-",4.5196150213464055,Pentose phosphate pathway
hsa00230,0.4563431710356223,"1% O2, CyA- vs 19% O2, CyA-",0.34070844410115925,Purine metabolism
hsa04211,0.0,"1% O2, CyA- vs 19% O2, CyA-",inf,Longevity regulating pathway
hsa04611,0.08835370666267611,"1% O2, CyA- vs 19% O2, CyA-",1.0537752260171063,Platelet activation
hsa04012,0.06780467040648466,"1% O2, CyA- vs 19% O2, CyA-",1.1687403907655787,ErbB signaling pathway
hsa04728,0.3628466023570981,"1% O2, CyA- vs 19% O2, CyA-",0.4402769392338716,Dopaminergic synapse
hsa05219,0.40551454541280607,"1% O2, CyA- vs 19% O2, CyA-",0.39199356345227,Bladder cancer
hsa00600,0.14247360357924777,"1% O2, CyA- vs 19% O2, CyA-",0.8462655909661628,Sphingolipid metabolism
hsa04972,0.023822819060371123,"1% O2, CyA- vs 19% O2, CyA-",1.6230068478103405,Pancreatic secretion
hsa04360,2.2009196687389733e-11,"1% O2, CyA- vs 19% O2, CyA-",10.657395808450767,Axon guidance
hsa04722,0.08753243645907965,"1% O2, CyA- vs 19% O2, CyA-",1.0578309828085646,Neurotrophin signaling pathway
hsa00512,0.5336208825960868,"1% O2, CyA- vs 19% O2, CyA-",0.2727671831792322,Mucin type O-glycan biosynthesis
hsa04723,0.48013781513753045,"1% O2, CyA- vs 19% O2, CyA-",0.31863408811785837,Retrograde endocannabinoid signaling
hsa00601,0.5220835729975929,"1% O2, CyA- vs 19% O2, CyA-",0.2822599713530349,Glycosphingolipid biosynthesis - lacto and neolacto series
hsa05204,0.2611862499211093,"1% O2, CyA- vs 19% O2, CyA-",0.583049690109718,Chemical carcinogenesis - DNA adducts
hsa04071,5.895144416281214e-26,"1% O2, CyA- vs 19% O2, CyA-",25.22950555131091,Sphingolipid signaling pathway
hsa04213,4.1407202865986655e-12,"1% O2, CyA- vs 19% O2, CyA-",11.382924105911448,Longevity regulating pathway - multiple species
hsa04270,6.876193537364637e-08,"1% O2, CyA- vs 19% O2, CyA-",7.162651908159123,Vascular smooth muscle contraction
hsa04918,0.0011019323867518145,"1% O2, CyA- vs 19% O2, CyA-",2.957845052454691,Thyroid hormone synthesis
hsa04657,0.4160425336715611,"1% O2, CyA- vs 19% O2, CyA-",0.3808622674632043,IL-17 signaling pathway
hsa04622,0.1192117416375933,"1% O2, CyA- vs 19% O2, CyA-",0.9236809671018186,RIG-I-like receptor signaling pathway
hsa00052,0.3607234361133621,"1% O2, CyA- vs 19% O2, CyA-",0.44282564075880215,Galactose metabolism
hsa00515,0.5430459596762115,"1% O2, CyA- vs 19% O2, CyA-",0.26516341315681624,Mannose type O-glycan biosynthesis
hsa04659,0.19560492022992165,"1% O2, CyA- vs 19% O2, CyA-",0.7086202252036851,Th17 cell differentiation
hsa00270,0.07846276052470118,"1% O2, CyA- vs 19% O2, CyA-",1.1053364163243167,Cysteine and methionine metabolism
hsa04915,0.08179371080848419,"1% O2, CyA- vs 19% O2, CyA-",1.0872800883357265,Estrogen signaling pathway
hsa04216,0.27629494521591513,"1% O2, CyA- vs 19% O2, CyA-",0.5586270603781547,Ferroptosis
hsa04512,0.36878027144583403,"1% O2, CyA- vs 19% O2, CyA-",0.4332323203499331,ECM-receptor interaction
hsa04510,3.6396375814036295e-10,"1% O2, CyA- vs 19% O2, CyA-",9.438941859272013,Focal adhesion
hsa04668,3.0659244782236724e-10,"1% O2, CyA- vs 19% O2, CyA-",9.513438547164187,TNF signaling pathway
hsa05226,5.398648573633083e-05,"1% O2, CyA- vs 19% O2, CyA-",4.267714942115596,Gastric cancer
hsa00770,0.5226916925743138,"1% O2, CyA- vs 19% O2, CyA-",0.2817544023277423,Pantothenate and CoA biosynthesis
hsa05131,0.07417849022874291,"1% O2, CyA- vs 19% O2, CyA-",1.1297220102093297,Shigellosis
hsa01522,4.977504003100229e-06,"1% O2, CyA- vs 19% O2, CyA-",5.302988382024081,Endocrine resistance
hsa04062,0.1878473003923422,"1% O2, CyA- vs 19% O2, CyA-",0.7261950419268338,Chemokine signaling pathway
hsa04911,2.148056733892214e-06,"1% O2, CyA- vs 19% O2, CyA-",5.667954252352864,Insulin secretion
hsa00040,0.5310700784586456,"1% O2, CyA- vs 19% O2, CyA-",0.2748481669039068,Pentose and glucuronate interconversions
hsa04930,0.022999388809803567,"1% O2, CyA- vs 19% O2, CyA-",1.6382837048544312,Type II diabetes mellitus
hsa05202,0.00025823480688364186,"1% O2, CyA- vs 19% O2, CyA-",3.587985220556442,Transcriptional misregulation in cancer
hsa05145,0.030476775783946065,"1% O2, CyA- vs 19% O2, CyA-",1.5160309800262226,Toxoplasmosis
hsa04380,0.014328230759994965,"1% O2, CyA- vs 19% O2, CyA-",1.8438074326737208,Osteoclast differentiation
hsa04010,0.021190893650407938,"1% O2, CyA- vs 19% O2, CyA-",1.6738507280812167,MAPK signaling pathway
hsa05142,0.47666288109289306,"1% O2, CyA- vs 19% O2, CyA-",0.3217886663322141,Chagas disease
hsa00020,0.29832515011107397,"1% O2, CyA- vs 19% O2, CyA-",0.5253101321758646,Citrate cycle (TCA cycle)
hsa04744,0.5116587776151668,"1% O2, CyA- vs 19% O2, CyA-",0.29101957105879667,Phototransduction
hsa04921,0.24288280592780076,"1% O2, CyA- vs 19% O2, CyA-",0.614603228525385,Oxytocin signaling pathway
hsa05225,0.005106064832083242,"19% O2, CyA- vs 1% O2, CyA+",2.2919136752275673,Hepatocellular carcinoma
hsa04962,0.4956535297565384,"19% O2, CyA- vs 1% O2, CyA+",0.3048217966816041,Vasopressin-regulated water reabsorption
hsa03250,7.229198030922383e-91,"19% O2, CyA- vs 1% O2, CyA+",90.14090987837119,Viral life cycle - HIV-1
hsa04912,6.293763079416012e-09,"19% O2, CyA- vs 1% O2, CyA+",8.201089609570065,GnRH signaling pathway
hsa05218,2.580130036093183e-14,"19% O2, CyA- vs 1% O2, CyA+",13.588358405457477,Melanoma
hsa00100,2.633989924871417e-05,"19% O2, CyA- vs 1% O2, CyA+",4.579385890566762,Steroid biosynthesis
hsa00830,0.5011784697553012,"19% O2, CyA- vs 1% O2, CyA+",0.3000075942367628,Retinol metabolism
hsa00785,0.5175870739551677,"19% O2, CyA- vs 1% O2, CyA+",0.28601657812768755,Lipoic acid metabolism
hsa04625,0.1322034494838749,"19% O2, CyA- vs 1% O2, CyA+",0.8787572129875356,C-type lectin receptor signaling pathway
hsa05221,0.0012681974176613339,"19% O2, CyA- vs 1% O2, CyA+",2.8968131354705955,Acute myeloid leukemia
hsa04145,1.1227106609784074e-16,"19% O2, CyA- vs 1% O2, CyA+",15.94973215338332,Phagosome
hsa05217,0.4905673770421456,"19% O2, CyA- vs 1% O2, CyA+",0.3093013359536392,Basal cell carcinoma
hsa05223,0.01522621702207983,"19% O2, CyA- vs 1% O2, CyA+",1.8174079844192326,Non-small cell lung cancer
hsa05330,0.5423519313079062,"19% O2, CyA- vs 1% O2, CyA+",0.2657188089876387,Allograft rejection
hsa04022,0.31184910926114595,"19% O2, CyA- vs 1% O2, CyA+",0.5060554920923159,cGMP-PKG signaling pathway
hsa00140,0.5000032362868404,"19% O2, CyA- vs 1% O2, CyA+",0.3010271846700451,Steroid hormone biosynthesis
hsa04066,0.01660160921308491,"19% O2, CyA- vs 1% O2, CyA+",1.7798498132556895,HIF-1 signaling pathway
hsa04724,0.492849647112792,"19% O2, CyA- vs 1% O2, CyA+",0.3072855500703021,Glutamatergic synapse
hsa05012,0.2649124677031012,"19% O2, CyA- vs 1% O2, CyA+",0.576897601811336,Parkinson disease
hsa05146,0.3653228690874073,"19% O2, CyA- vs 1% O2, CyA+",0.4373231402501876,Amoebiasis
hsa05410,0.41090989206379497,"19% O2, CyA- vs 1% O2, CyA+",0.38625340359816873,Hypertrophic cardiomyopathy
hsa00510,0.49949599477445783,"19% O2, CyA- vs 1% O2, CyA+",0.3014679898290412,N-Glycan biosynthesis
hsa04114,0.004164935576461658,"19% O2, CyA- vs 1% O2, CyA+",2.3803917119051157,Oocyte meiosis
hsa04310,0.029033500582410377,"19% O2, CyA- vs 1% O2, CyA+",1.5371005979275427,Wnt signaling pathway
hsa03015,3.6574097255377106e-27,"19% O2, CyA- vs 1% O2, CyA+",26.43682638459696,mRNA surveillance pathway
hsa03440,0.013688435319287469,"19% O2, CyA- vs 1% O2, CyA+",1.8636461918247738,Homologous recombination
hsa05152,1.2652804727843314e-06,"19% O2, CyA- vs 1% O2, CyA+",5.897813194424061,Tuberculosis
hsa04110,2.671848683416989e-33,"19% O2, CyA- vs 1% O2, CyA+",32.573188141188204,Cell cycle
hsa00604,0.5180364196991846,"19% O2, CyA- vs 1% O2, CyA+",0.2856397068215899,Glycosphingolipid biosynthesis - ganglio series
hsa05416,3.313013779400642e-50,"19% O2, CyA- vs 1% O2, CyA+",49.47977675780798,Viral myocarditis
hsa04664,0.0,"19% O2, CyA- vs 1% O2, CyA+",inf,Fc epsilon RI signaling pathway
hsa04929,0.22907816602646203,"19% O2, CyA- vs 1% O2, CyA+",0.6400163024566295,GnRH secretion
hsa04136,0.0,"19% O2, CyA- vs 1% O2, CyA+",inf,Autophagy - other
hsa04660,0.00034928061469021604,"19% O2, CyA- vs 1% O2, CyA+",3.456825517330269,T cell receptor signaling pathway
hsa00310,0.022041530587987027,"19% O2, CyA- vs 1% O2, CyA+",1.65675825088937,Lysine degradation
hsa04070,0.009940011323346,"19% O2, CyA- vs 1% O2, CyA+",2.0026131208678897,Phosphatidylinositol signaling system
hsa04726,0.0868034830217495,"19% O2, CyA- vs 1% O2, CyA+",1.061462848247727,Serotonergic synapse
hsa05332,0.5488457327045414,"19% O2, CyA- vs 1% O2, CyA+",0.2605497080999175,Graft-versus-host disease
hsa04916,0.4663986685910709,"19% O2, CyA- vs 1% O2, CyA+",0.3312426980097121,Melanogenesis
hsa05169,0.2261040368191728,"19% O2, CyA- vs 1% O2, CyA+",0.6456916837729918,Epstein-Barr virus infection
hsa00900,0.2608994698523722,"19% O2, CyA- vs 1% O2, CyA+",0.5835268033851118,Terpenoid backbone biosynthesis
hsa00591,0.5283834565041745,"19% O2, CyA- vs 1% O2, CyA+",0.2770507884485459,Linoleic acid metabolism
hsa04024,0.21669958283321533,"19% O2, CyA- vs 1% O2, CyA+",0.6641419247365133,cAMP signaling pathway
hsa04068,6.632225646468499e-31,"19% O2, CyA- vs 1% O2, CyA+",30.178340706319506,FoxO signaling pathway
hsa00520,0.1255709691678933,"19% O2, CyA- vs 1% O2, CyA+",0.9011107538113576,Amino sugar and nucleotide sugar metabolism
hsa00860,0.5081506278811053,"19% O2, CyA- vs 1% O2, CyA+",0.2940075334619986,Porphyrin metabolism
hsa04922,1.1973591380985948e-90,"19% O2, CyA- vs 1% O2, CyA+",89.92177556696961,Glucagon signaling pathway
hsa04926,0.27324779241704467,"19% O2, CyA- vs 1% O2, CyA+",0.5634433380515211,Relaxin signaling pathway
hsa04370,3.095585616805934e-08,"19% O2, CyA- vs 1% O2, CyA+",7.5092571798945995,VEGF signaling pathway
hsa05213,5.264545625510761e-118,"19% O2, CyA- vs 1% O2, CyA+",117.2786391061212,Endometrial cancer
hsa04520,3.2078112710026256e-23,"19% O2, CyA- vs 1% O2, CyA+",22.49379119100297,Adherens junction
hsa05110,0.003744733015124382,"19% O2, CyA- vs 1% O2, CyA+",2.426579140365457,Vibrio cholerae infection
hsa05220,0.2911862614916798,"19% O2, CyA- vs 1% O2, CyA+",0.5358291193971372,Chronic myeloid leukemia
hsa05235,0.00046265743150179946,"19% O2, CyA- vs 1% O2, CyA+",3.3347404575226656,PD-L1 expression and PD-1 checkpoint pathway in cancer
hsa05207,5.752899458387627e-10,"19% O2, CyA- vs 1% O2, CyA+",9.240113215936088,Chemical carcinogenesis - receptor activation
hsa05418,0.006488595412488315,"19% O2, CyA- vs 1% O2, CyA+",2.187849304836737,Fluid shear stress and atherosclerosis
hsa00920,0.4842313965073756,"19% O2, CyA- vs 1% O2, CyA+",0.3149470552745995,Sulfur metabolism
hsa04931,0.002276288923421387,"19% O2, CyA- vs 1% O2, CyA+",2.6427726149114235,Insulin resistance
hsa00500,0.29174351575102475,"19% O2, CyA- vs 1% O2, CyA+",0.5349987877413542,Starch and sucrose metabolism
hsa05216,0.2153931849938584,"19% O2, CyA- vs 1% O2, CyA+",0.6667680418290468,Thyroid cancer
hsa00740,0.4221092685739638,"19% O2, CyA- vs 1% O2, CyA+",0.374575111606942,Riboflavin metabolism
hsa00062,0.508050176768503,"19% O2, CyA- vs 1% O2, CyA+",0.2940933931933563,Fatty acid elongation
hsa04390,0.46725987093163135,"19% O2, CyA- vs 1% O2, CyA+",0.33044151531915106,Hippo signaling pathway
hsa04064,0.2656683551026706,"19% O2, CyA- vs 1% O2, CyA+",0.5756601731876301,NF-kappa B signaling pathway
hsa04932,1.1299508956474799e-15,"19% O2, CyA- vs 1% O2, CyA+",14.946940429271189,Non-alcoholic fatty liver disease
hsa05222,0.43962764772066265,"19% O2, CyA- vs 1% O2, CyA+",0.35691500306621915,Small cell lung cancer
hsa05320,0.5459151116703447,"19% O2, CyA- vs 1% O2, CyA+",0.26287488366764744,Autoimmune thyroid disease
hsa04115,0.06563700859139524,"19% O2, CyA- vs 1% O2, CyA+",1.1828512201517625,p53 signaling pathway
hsa04710,8.806634706027405e-184,"19% O2, CyA- vs 1% O2, CyA+",183.05519001756014,Circadian rhythm
hsa05206,0.033388612503257725,"19% O2, CyA- vs 1% O2, CyA+",1.476401628106429,MicroRNAs in cancer
hsa05032,0.4949968616541113,"19% O2, CyA- vs 1% O2, CyA+",0.3053975545424363,Morphine addiction
hsa00620,0.45904940050421744,"19% O2, CyA- vs 1% O2, CyA+",0.3381405754389045,Pyruvate metabolism
hsa05132,3.425564568907648e-14,"19% O2, CyA- vs 1% O2, CyA+",13.465267841994836,Salmonella infection
hsa04658,0.29707905753830033,"19% O2, CyA- vs 1% O2, CyA+",0.5271279625219067,Th1 and Th2 cell differentiation
hsa05014,2.859400670899355e-81,"19% O2, CyA- vs 1% O2, CyA+",80.54372498526159,Amyotrophic lateral sclerosis
hsa04933,0.45365113043762484,"19% O2, CyA- vs 1% O2, CyA+",0.3432780025818945,AGE-RAGE signaling pathway in diabetic complications
hsa00531,0.46711256564005355,"19% O2, CyA- vs 1% O2, CyA+",0.3305784497433987,Glycosaminoglycan degradation
hsa04714,6.370672054082357e-05,"19% O2, CyA- vs 1% O2, CyA+",4.19581475071268,Thermogenesis
hsa00592,0.30604576228985303,"19% O2, CyA- vs 1% O2, CyA+",0.5142136296491083,alpha-Linolenic acid metabolism
hsa05170,0.2353086920834347,"19% O2, CyA- vs 1% O2, CyA+",0.6283620300949095,Human immunodeficiency virus 1 infection
hsa05160,0.00021893941810681184,"19% O2, CyA- vs 1% O2, CyA+",3.659676040510119,Hepatitis C
hsa04392,0.31850382482047457,"19% O2, CyA- vs 1% O2, CyA+",0.49688534798027123,Hippo signaling pathway - multiple species
hsa04666,9.436627547183988e-17,"19% O2, CyA- vs 1% O2, CyA+",16.02518318571599,Fc gamma R-mediated phagocytosis
hsa04920,0.4396063289589641,"19% O2, CyA- vs 1% O2, CyA+",0.35693606371859177,Adipocytokine signaling pathway
hsa04940,0.5407061241402084,"19% O2, CyA- vs 1% O2, CyA+",0.2670387114947715,Type I diabetes mellitus
hsa04672,0.26446511255770633,"19% O2, CyA- vs 1% O2, CyA+",0.5776316106722625,Intestinal immune network for IgA production
hsa00780,0.5555909221827697,"19% O2, CyA- vs 1% O2, CyA+",0.25524485882739995,Biotin metabolism
hsa00590,0.4697356753908605,"19% O2, CyA- vs 1% O2, CyA+",0.3281464548539617,Arachidonic acid metabolism
hsa05161,0.020183882892251055,"19% O2, CyA- vs 1% O2, CyA+",1.694995282278269,Hepatitis B
hsa04540,0.1566791703199955,"19% O2, CyA- vs 1% O2, CyA+",0.8049887368842032,Gap junction
hsa04913,1.8867183267702394e-07,"19% O2, CyA- vs 1% O2, CyA+",6.724292931981519,Ovarian steroidogenesis
hsa05212,0.3645692646052796,"19% O2, CyA- vs 1% O2, CyA+",0.4382199477901426,Pancreatic cancer
hsa05211,0.020627595673602735,"19% O2, CyA- vs 1% O2, CyA+",1.685551389891082,Renal cell carcinoma
hsa04371,0.0008309414542892386,"19% O2, CyA- vs 1% O2, CyA+",3.0804295742602035,Apelin signaling pathway
hsa05164,0.4073682079441559,"19% O2, CyA- vs 1% O2, CyA+",0.3900128674644229,Influenza A
hsa04146,0.0012598300748799338,"19% O2, CyA- vs 1% O2, CyA+",2.8996880283099307,Peroxisome
hsa04122,0.1969883426844828,"19% O2, CyA- vs 1% O2, CyA+",0.705559473623177,Sulfur relay system
hsa05167,0.159191470432881,"19% O2, CyA- vs 1% O2, CyA+",0.7980802057137482,Kaposi sarcoma-associated herpesvirus infection
hsa00562,0.2094771672991509,"19% O2, CyA- vs 1% O2, CyA+",0.6788633075730418,Inositol phosphate metabolism
hsa04935,3.133006854780318e-07,"19% O2, CyA- vs 1% O2, CyA+",6.504038654914014,"Growth hormone synthesis, secretion and action"
hsa00240,0.37105524033312315,"19% O2, CyA- vs 1% O2, CyA+",0.43056143058445884,Pyrimidine metabolism
hsa05200,4.356787918308777e-10,"19% O2, CyA- vs 1% O2, CyA+",9.36083358033277,Pathways in cancer
hsa00480,0.49142924343708655,"19% O2, CyA- vs 1% O2, CyA+",0.3085390035631533,Glutathione metabolism
hsa04150,1.0596769567735707e-05,"19% O2, CyA- vs 1% O2, CyA+",4.974826509521201,mTOR signaling pathway
hsa05034,0.017616073458740694,"19% O2, CyA- vs 1% O2, CyA+",1.7540908873675995,Alcoholism
hsa04750,0.4922825650130592,"19% O2, CyA- vs 1% O2, CyA+",0.3077855451996286,Inflammatory mediator regulation of TRP channels
hsa04137,0.11196242209459906,"19% O2, CyA- vs 1% O2, CyA+",0.9509277149670312,Mitophagy - animal
hsa05203,4.494033905639625e-06,"19% O2, CyA- vs 1% O2, CyA+",5.347363655331076,Viral carcinogenesis
hsa03320,0.5021907010146072,"19% O2, CyA- vs 1% O2, CyA+",0.2991313333105382,PPAR signaling pathway
hsa00564,0.4994124148530037,"19% O2, CyA- vs 1% O2, CyA+",0.30154066575892685,Glycerophospholipid metabolism
hsa04961,0.48188855366560557,"19% O2, CyA- vs 1% O2, CyA+",0.317053389405171,Endocrine and other factor-regulated calcium reabsorption
hsa00220,0.5144150640845517,"19% O2, CyA- vs 1% O2, CyA+",0.2886863220570002,Arginine biosynthesis
hsa05168,6.518410264629023e-11,"19% O2, CyA- vs 1% O2, CyA+",10.185858308789982,Herpes simplex virus 1 infection
hsa04061,2.5189677120335234e-05,"19% O2, CyA- vs 1% O2, CyA+",4.598777399225008,Viral protein interaction with cytokine and cytokine receptor
hsa05412,0.31404862616160983,"19% O2, CyA- vs 1% O2, CyA+",0.5030031021221495,Arrhythmogenic right ventricular cardiomyopathy
hsa04924,0.3396780714681531,"19% O2, CyA- vs 1% O2, CyA+",0.46893248889026695,Renin secretion
hsa05143,0.44344807923827206,"19% O2, CyA- vs 1% O2, CyA+",0.3531572218758243,African trypanosomiasis
hsa04960,0.3423076939273588,"19% O2, CyA- vs 1% O2, CyA+",0.46558333927099305,Aldosterone-regulated sodium reabsorption
hsa05162,0.36396708629597113,"19% O2, CyA- vs 1% O2, CyA+",0.4389378880167035,Measles
hsa00730,0.43494691670739005,"19% O2, CyA- vs 1% O2, CyA+",0.3615637434771077,Thiamine metabolism
hsa05030,0.047208569971625466,"19% O2, CyA- vs 1% O2, CyA+",1.3259791548925814,Cocaine addiction
hsa00750,0.4512131552328036,"19% O2, CyA- vs 1% O2, CyA+",0.34561824687549336,Vitamin B6 metabolism
hsa04623,0.44222916414549507,"19% O2, CyA- vs 1% O2, CyA+",0.35435261994408573,Cytosolic DNA-sensing pathway
hsa00650,0.2374657782668788,"19% O2, CyA- vs 1% O2, CyA+",0.6243989686947984,Butanoate metabolism
hsa05010,0.3671854773668734,"19% O2, CyA- vs 1% O2, CyA+",0.4351145040071641,Alzheimer disease
hsa05031,5.819434167372123e-07,"19% O2, CyA- vs 1% O2, CyA+",6.235119240424738,Amphetamine addiction
hsa00071,0.17645039825385,"19% O2, CyA- vs 1% O2, CyA+",0.7533773570872125,Fatty acid degradation
hsa00561,0.3735031040859977,"19% O2, CyA- vs 1% O2, CyA+",0.427705784526445,Glycerolipid metabolism
hsa04614,0.45753768953168983,"19% O2, CyA- vs 1% O2, CyA+",0.3395731252446353,Renin-angiotensin system
hsa04971,0.2943097656736234,"19% O2, CyA- vs 1% O2, CyA+",0.5311953270685802,Gastric acid secretion
hsa04215,7.73264364689362e-11,"19% O2, CyA- vs 1% O2, CyA+",10.111672003497588,Apoptosis - multiple species
hsa04080,0.3220673536699014,"19% O2, CyA- vs 1% O2, CyA+",0.49205329517277663,Neuroactive ligand-receptor interaction
hsa05231,0.38146319285788044,"19% O2, CyA- vs 1% O2, CyA+",0.4185473604873191,Choline metabolism in cancer
hsa05166,3.656636185059245e-15,"19% O2, CyA- vs 1% O2, CyA+",14.436918247395383,Human T-cell leukemia virus 1 infection
hsa00790,0.4493211827887733,"19% O2, CyA- vs 1% O2, CyA+",0.34744310655404775,Folate biosynthesis
hsa00983,0.3278652105979354,"19% O2, CyA- vs 1% O2, CyA+",0.48430466337610034,Drug metabolism - other enzymes
hsa04721,0.012170436391940133,"19% O2, CyA- vs 1% O2, CyA+",1.9146938491147438,Synaptic vesicle cycle
hsa04218,0.002536234995338147,"19% O2, CyA- vs 1% O2, CyA+",2.595810509287773,Cellular senescence
hsa04530,7.530057464694936e-17,"19% O2, CyA- vs 1% O2, CyA+",16.123201709522448,Tight junction
hsa04340,0.38800824881399226,"19% O2, CyA- vs 1% O2, CyA+",0.4111590414771359,Hedgehog signaling pathway
hsa04725,9.915603858397343e-06,"19% O2, CyA- vs 1% O2, CyA+",5.003680832201583,Cholinergic synapse
hsa04740,0.5100568604437185,"19% O2, CyA- vs 1% O2, CyA+",0.2923814066462641,Olfactory transduction
hsa04152,5.3304417594812505e-06,"19% O2, CyA- vs 1% O2, CyA+",5.2732367973984005,AMPK signaling pathway
hsa03460,1.2350139578104935e-37,"19% O2, CyA- vs 1% O2, CyA+",36.90832813409191,Fanconi anemia pathway
hsa05214,0.005811767811843936,"19% O2, CyA- vs 1% O2, CyA+",2.23569174469219,Glioma
hsa00440,0.5326074966354245,"19% O2, CyA- vs 1% O2, CyA+",0.2735927250084469,Phosphonate and phosphinate metabolism
hsa04020,0.35197554648746177,"19% O2, CyA- vs 1% O2, CyA+",0.45348750809704874,Calcium signaling pathway
hsa04514,5.1320191712922384e-33,"19% O2, CyA- vs 1% O2, CyA+",32.28971172993334,Cell adhesion molecules
hsa04613,7.809018463257453e-45,"19% O2, CyA- vs 1% O2, CyA+",44.107403550345474,Neutrophil extracellular trap formation
hsa00250,0.45216468451418257,"19% O2, CyA- vs 1% O2, CyA+",0.34470336043282446,"Alanine, aspartate and glutamate metabolism"
hsa04217,0.04561593190931785,"19% O2, CyA- vs 1% O2, CyA+",1.3408834483034155,Necroptosis
hsa04934,0.0019306813366475745,"19% O2, CyA- vs 1% O2, CyA+",2.714289401599174,Cushing syndrome
hsa05140,0.0019223227432598083,"19% O2, CyA- vs 1% O2, CyA+",2.716173695829918,Leishmaniasis
hsa04919,2.589650700814079e-299,"19% O2, CyA- vs 1% O2, CyA+",298.58675881079876,Thyroid hormone signaling pathway
hsa04550,0.037263989249155985,"19% O2, CyA- vs 1% O2, CyA+",1.4287106541054686,Signaling pathways regulating pluripotency of stem cells
hsa00061,1.956917209072279e-05,"19% O2, CyA- vs 1% O2, CyA+",4.708427547568179,Fatty acid biosynthesis
hsa00532,0.4694599786092713,"19% O2, CyA- vs 1% O2, CyA+",0.3284014253573958,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
hsa04742,0.4084011613603634,"19% O2, CyA- vs 1% O2, CyA+",0.3889130315908076,Taste transduction
hsa04261,0.09352290061576413,"19% O2, CyA- vs 1% O2, CyA+",1.0290820319800367,Adrenergic signaling in cardiomyocytes
hsa04910,0.015947332161140037,"19% O2, CyA- vs 1% O2, CyA+",1.7973119599173863,Insulin signaling pathway
hsa04015,0.00011147659319708934,"19% O2, CyA- vs 1% O2, CyA+",3.952816312100041,Rap1 signaling pathway
hsa05208,0.04392884046439944,"19% O2, CyA- vs 1% O2, CyA+",1.3572502601209537,Chemical carcinogenesis - reactive oxygen species
hsa04914,1.0441329558289737e-76,"19% O2, CyA- vs 1% O2, CyA+",75.98124419644259,Progesterone-mediated oocyte maturation
hsa04130,0.32720764373669575,"19% O2, CyA- vs 1% O2, CyA+",0.4851765595426045,SNARE interactions in vesicular transport
hsa00640,8.088271128288767e-35,"19% O2, CyA- vs 1% O2, CyA+",34.09214429911511,Propanoate metabolism
hsa00450,0.4114351968290135,"19% O2, CyA- vs 1% O2, CyA+",0.385698558691903,Selenocompound metabolism
hsa04621,3.5681998712302487e-25,"19% O2, CyA- vs 1% O2, CyA+",24.447550826789964,NOD-like receptor signaling pathway
hsa05130,0.053380277153903775,"19% O2, CyA- vs 1% O2, CyA+",1.2726191756571927,Pathogenic Escherichia coli infection
hsa04670,0.2937849194598854,"19% O2, CyA- vs 1% O2, CyA+",0.5319705011374897,Leukocyte transendothelial migration
hsa04928,2.726850790972269e-111,"19% O2, CyA- vs 1% O2, CyA+",110.56433862532579,"Parathyroid hormone synthesis, secretion and action"
hsa00130,0.5241996177362576,"19% O2, CyA- vs 1% O2, CyA+",0.2805033000912392,Ubiquinone and other terpenoid-quinone biosynthesis
hsa05100,1.9315389842938658e-07,"19% O2, CyA- vs 1% O2, CyA+",6.714096522055609,Bacterial invasion of epithelial cells
hsa05414,0.18630762495653785,"19% O2, CyA- vs 1% O2, CyA+",0.7297693704994401,Dilated cardiomyopathy
hsa05321,0.48871134273446426,"19% O2, CyA- vs 1% O2, CyA+",0.31094758110724635,Inflammatory bowel disease
hsa00051,4.882039059553199e-06,"19% O2, CyA- vs 1% O2, CyA+",5.311398750260788,Fructose and mannose metabolism
hsa05230,0.07347044561909753,"19% O2, CyA- vs 1% O2, CyA+",1.1338873260283855,Central carbon metabolism in cancer
hsa04727,0.02474890683657404,"19% O2, CyA- vs 1% O2, CyA+",1.60644397916793,GABAergic synapse
hsa04630,0.23674327939967627,"19% O2, CyA- vs 1% O2, CyA+",0.6257223407769094,JAK-STAT signaling pathway
hsa00603,0.5087001525996984,"19% O2, CyA- vs 1% O2, CyA+",0.2935381320891151,Glycosphingolipid biosynthesis - globo and isoglobo series
hsa00340,0.48280998397191777,"19% O2, CyA- vs 1% O2, CyA+",0.3162237577563798,Histidine metabolism
hsa04610,0.5071540592960555,"19% O2, CyA- vs 1% O2, CyA+",0.29486009404166325,Complement and coagulation cascades
hsa05205,0.07017784161966108,"19% O2, CyA- vs 1% O2, CyA+",1.1537999930183862,Proteoglycans in cancer
hsa04140,8.414738411466196e-29,"19% O2, CyA- vs 1% O2, CyA+",28.074959380368202,Autophagy - animal
hsa00010,0.41292368404687585,"19% O2, CyA- vs 1% O2, CyA+",0.38413020660003966,Glycolysis / Gluconeogenesis
hsa04144,1.0761468979306458e-19,"19% O2, CyA- vs 1% O2, CyA+",18.96812844186087,Endocytosis
hsa01521,0.00024986330801219384,"19% O2, CyA- vs 1% O2, CyA+",3.6022975145730287,EGFR tyrosine kinase inhibitor resistance
hsa05415,0.2678764744728692,"19% O2, CyA- vs 1% O2, CyA+",0.5720654254557856,Diabetic cardiomyopathy
hsa05133,0.04057855547525753,"19% O2, CyA- vs 1% O2, CyA+",1.3917034171422675,Pertussis
hsa04620,1.9570651647226723e-05,"19% O2, CyA- vs 1% O2, CyA+",4.708394713326005,Toll-like receptor signaling pathway
hsa00980,0.4721841939234026,"19% O2, CyA- vs 1% O2, CyA+",0.32588855475567774,Metabolism of xenobiotics by cytochrome P450
hsa01524,9.638122338468272e-12,"19% O2, CyA- vs 1% O2, CyA+",11.016007565419693,Platinum drug resistance
hsa00630,0.4270373983801635,"19% O2, CyA- vs 1% O2, CyA+",0.3695340893803328,Glyoxylate and dicarboxylate metabolism
hsa05022,0.00019831743785401684,"19% O2, CyA- vs 1% O2, CyA+",3.7026390970361716,Pathways of neurodegeneration - multiple diseases
hsa05165,0.18999776488372994,"19% O2, CyA- vs 1% O2, CyA+",0.7212515080175504,Human papillomavirus infection
hsa04330,0.4801398501841752,"19% O2, CyA- vs 1% O2, CyA+",0.318632247380413,Notch signaling pathway
hsa04927,0.0034804488367799814,"19% O2, CyA- vs 1% O2, CyA+",2.4583647460627813,Cortisol synthesis and secretion
hsa01523,0.18123063554975027,"19% O2, CyA- vs 1% O2, CyA+",0.7417683865399705,Antifolate resistance
hsa05323,0.42281934180208813,"19% O2, CyA- vs 1% O2, CyA+",0.3738451541796898,Rheumatoid arthritis
hsa00563,0.5188387521263267,"19% O2, CyA- vs 1% O2, CyA+",0.28496759387149856,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
hsa04917,0.07105726786723683,"19% O2, CyA- vs 1% O2, CyA+",1.148391495031237,Prolactin signaling pathway
hsa05135,2.151388130352237e-10,"19% O2, CyA- vs 1% O2, CyA+",9.667281231795629,Yersinia infection
hsa04612,0.45756324471549814,"19% O2, CyA- vs 1% O2, CyA+",0.33954886895792524,Antigen processing and presentation
hsa00330,0.5276759089252816,"19% O2, CyA- vs 1% O2, CyA+",0.2776327331104364,Arginine and proline metabolism
hsa05016,3.47620702117925e-05,"19% O2, CyA- vs 1% O2, CyA+",4.458894367586274,Huntington disease
hsa04141,3.858935044972098e-11,"19% O2, CyA- vs 1% O2, CyA+",10.413532531573098,Protein processing in endoplasmic reticulum
hsa04979,0.06466688265512924,"19% O2, CyA- vs 1% O2, CyA+",1.1893180742362282,Cholesterol metabolism
hsa00670,0.4388267886959313,"19% O2, CyA- vs 1% O2, CyA+",0.35770686827211695,One carbon pool by folate
hsa00260,0.5189790499980287,"19% O2, CyA- vs 1% O2, CyA+",0.28485017327657447,"Glycine, serine and threonine metabolism"
hsa04730,1.0468141433561445e-22,"19% O2, CyA- vs 1% O2, CyA+",21.980130418301897,Long-term depression
hsa04650,3.016405567242415e-41,"19% O2, CyA- vs 1% O2, CyA+",40.52051026632553,Natural killer cell mediated cytotoxicity
hsa04720,3.843581329334604e-18,"19% O2, CyA- vs 1% O2, CyA+",17.415263924921877,Long-term potentiation
hsa00360,0.5297324243840894,"19% O2, CyA- vs 1% O2, CyA+",0.27594344352633143,Phenylalanine metabolism
hsa05020,5.2566678746659485e-06,"19% O2, CyA- vs 1% O2, CyA+",5.279289461588471,Prion disease
hsa00760,0.522066856662137,"19% O2, CyA- vs 1% O2, CyA+",0.2822738770356655,Nicotinate and nicotinamide metabolism
hsa05210,6.333909251695284e-13,"19% O2, CyA- vs 1% O2, CyA+",12.198328163220234,Colorectal cancer
hsa03018,0.274567538532903,"19% O2, CyA- vs 1% O2, CyA+",0.5613508096680134,RNA degradation
hsa00410,0.5176032999290582,"19% O2, CyA- vs 1% O2, CyA+",0.28600296352866783,beta-Alanine metabolism
hsa00565,0.4783582419340845,"19% O2, CyA- vs 1% O2, CyA+",0.32024673890496186,Ether lipid metabolism
hsa04350,0.41730530301702495,"19% O2, CyA- vs 1% O2, CyA+",0.37954609634173503,TGF-beta signaling pathway
hsa05150,0.428416448317521,"19% O2, CyA- vs 1% O2, CyA+",0.368133863525512,Staphylococcus aureus infection
hsa00120,0.5618937988857463,"19% O2, CyA- vs 1% O2, CyA+",0.2503457607945159,Primary bile acid biosynthesis
hsa04810,1.8833451995178253e-28,"19% O2, CyA- vs 1% O2, CyA+",27.725070070580465,Regulation of actin cytoskeleton
hsa05144,0.509198183572303,"19% O2, CyA- vs 1% O2, CyA+",0.29311315424448714,Malaria
hsa04072,2.452915799953046e-31,"19% O2, CyA- vs 1% O2, CyA+",30.610317359353086,Phospholipase D signaling pathway
hsa00910,0.00036988808607696036,"19% O2, CyA- vs 1% O2, CyA+",3.431929656882393,Nitrogen metabolism
hsa00513,0.48595323791203876,"19% O2, CyA- vs 1% O2, CyA+",0.3134055198197064,Various types of N-glycan biosynthesis
hsa05134,0.36134905855722826,"19% O2, CyA- vs 1% O2, CyA+",0.442073072436036,Legionellosis
hsa04970,0.24342955036317282,"19% O2, CyA- vs 1% O2, CyA+",0.6136267030957323,Salivary secretion
hsa05171,0.4737705918496118,"19% O2, CyA- vs 1% O2, CyA+",0.32443190054406296,Coronavirus disease - COVID-19
hsa05017,4.2070423547699465e-13,"19% O2, CyA- vs 1% O2, CyA+",12.376023115662996,Spinocerebellar ataxia
hsa04976,0.4679321715529479,"19% O2, CyA- vs 1% O2, CyA+",0.3298170949069748,Bile secretion
hsa04060,0.11320560036909183,"19% O2, CyA- vs 1% O2, CyA+",0.9461320877305163,Cytokine-cytokine receptor interaction
hsa04925,2.482912416781493e-06,"19% O2, CyA- vs 1% O2, CyA+",5.605038599647756,Aldosterone synthesis and secretion
hsa00280,0.3060554017644528,"19% O2, CyA- vs 1% O2, CyA+",0.5141999509604427,"Valine, leucine and isoleucine degradation"
hsa00380,0.47185434199153475,"19% O2, CyA- vs 1% O2, CyA+",0.3261920442303868,Tryptophan metabolism
hsa04662,0.003035052456039912,"19% O2, CyA- vs 1% O2, CyA+",2.5178337984365635,B cell receptor signaling pathway
hsa00970,0.25226858158738674,"19% O2, CyA- vs 1% O2, CyA+",0.598136834670222,Aminoacyl-tRNA biosynthesis
hsa04936,0.2761307977526641,"19% O2, CyA- vs 1% O2, CyA+",0.5588851524041465,Alcoholic liver disease
hsa04923,0.3727719947003426,"19% O2, CyA- vs 1% O2, CyA+",0.4285567224016469,Regulation of lipolysis in adipocytes
hsa05215,1.7578637552839054e-05,"19% O2, CyA- vs 1% O2, CyA+",4.7550147883187615,Prostate cancer
hsa05224,0.012286856367410594,"19% O2, CyA- vs 1% O2, CyA+",1.9105592185720681,Breast cancer
hsa04014,0.09444593840912296,"19% O2, CyA- vs 1% O2, CyA+",1.0248167139140205,Ras signaling pathway
hsa04151,0.3379234305561577,"19% O2, CyA- vs 1% O2, CyA+",0.47118169455697323,PI3K-Akt signaling pathway
hsa05417,0.4380334340024481,"19% O2, CyA- vs 1% O2, CyA+",0.35849273961322564,Lipid and atherosclerosis
hsa04210,9.854771918694709e-16,"19% O2, CyA- vs 1% O2, CyA+",15.0063534226883,Apoptosis
hsa04713,4.795938552558708e-41,"19% O2, CyA- vs 1% O2, CyA+",40.319126389888375,Circadian entrainment
hsa05120,1.296670333267841e-07,"19% O2, CyA- vs 1% O2, CyA+",6.887170425335544,Epithelial cell signaling in Helicobacter pylori infection
hsa00350,0.5135123488981467,"19% O2, CyA- vs 1% O2, CyA+",0.2894491080670204,Tyrosine metabolism
hsa05322,0.5248506088707457,"19% O2, CyA- vs 1% O2, CyA+",0.27996429464308004,Systemic lupus erythematosus
hsa05163,0.20466988649543216,"19% O2, CyA- vs 1% O2, CyA+",0.6889460512843605,Human cytomegalovirus infection
hsa00030,4.012255244344512e-20,"19% O2, CyA- vs 1% O2, CyA+",19.39661144661764,Pentose phosphate pathway
hsa00230,0.4697871156970403,"19% O2, CyA- vs 1% O2, CyA+",0.3280988982829971,Purine metabolism
hsa04211,8.788928240700251e-28,"19% O2, CyA- vs 1% O2, CyA+",27.056064081414135,Longevity regulating pathway
hsa04611,0.00015473066432624208,"19% O2, CyA- vs 1% O2, CyA+",3.810423609843079,Platelet activation
hsa04012,0.0001352059427871969,"19% O2, CyA- vs 1% O2, CyA+",3.8690042191712646,ErbB signaling pathway
hsa04728,0.2188550747539013,"19% O2, CyA- vs 1% O2, CyA+",0.6598433786279108,Dopaminergic synapse
hsa05219,0.13743281451281675,"19% O2, CyA- vs 1% O2, CyA+",0.8619095594136672,Bladder cancer
hsa00600,0.40334131969168824,"19% O2, CyA- vs 1% O2, CyA+",0.3943272850717442,Sphingolipid metabolism
hsa04972,0.24408111550768896,"19% O2, CyA- vs 1% O2, CyA+",0.6124658205339271,Pancreatic secretion
hsa04360,1.3300043520692686e-213,"19% O2, CyA- vs 1% O2, CyA+",212.8761469379227,Axon guidance
hsa04722,0.006044807896373439,"19% O2, CyA- vs 1% O2, CyA+",2.218617496436071,Neurotrophin signaling pathway
hsa00512,0.5188190121595654,"19% O2, CyA- vs 1% O2, CyA+",0.28498411754420355,Mucin type O-glycan biosynthesis
hsa04723,0.4501868293806959,"19% O2, CyA- vs 1% O2, CyA+",0.346607214824075,Retrograde endocannabinoid signaling
hsa00601,0.5263199908115541,"19% O2, CyA- vs 1% O2, CyA+",0.2787501341927441,Glycosphingolipid biosynthesis - lacto and neolacto series
hsa05204,0.33205173996933535,"19% O2, CyA- vs 1% O2, CyA+",0.47879423969226204,Chemical carcinogenesis - DNA adducts
hsa04071,3.4076920485824757e-16,"19% O2, CyA- vs 1% O2, CyA+",15.467539659106107,Sphingolipid signaling pathway
hsa04213,2.9917451487841e-19,"19% O2, CyA- vs 1% O2, CyA+",18.524075404521074,Longevity regulating pathway - multiple species
hsa04270,6.511359239600294e-05,"19% O2, CyA- vs 1% O2, CyA+",4.1863283434378955,Vascular smooth muscle contraction
hsa04918,0.057161351760303986,"19% O2, CyA- vs 1% O2, CyA+",1.2428975094979435,Thyroid hormone synthesis
hsa04657,0.06626724115014634,"19% O2, CyA- vs 1% O2, CyA+",1.1787011096595192,IL-17 signaling pathway
hsa04622,0.2872524958329448,"19% O2, CyA- vs 1% O2, CyA+",0.5417361891957546,RIG-I-like receptor signaling pathway
hsa00052,0.3760119612880974,"19% O2, CyA- vs 1% O2, CyA+",0.42479833954363727,Galactose metabolism
hsa00515,0.5322572878011382,"19% O2, CyA- vs 1% O2, CyA+",0.2738783833792573,Mannose type O-glycan biosynthesis
hsa04659,0.32175283934937304,"19% O2, CyA- vs 1% O2, CyA+",0.4924776119190722,Th17 cell differentiation
hsa00270,0.49038022969807593,"19% O2, CyA- vs 1% O2, CyA+",0.3094670472704515,Cysteine and methionine metabolism
hsa04915,0.2863317541066747,"19% O2, CyA- vs 1% O2, CyA+",0.5431304861782276,Estrogen signaling pathway
hsa04216,0.002418489196563053,"19% O2, CyA- vs 1% O2, CyA+",2.6164558482728513,Ferroptosis
hsa04512,0.45878435427179376,"19% O2, CyA- vs 1% O2, CyA+",0.33839140107871457,ECM-receptor interaction
hsa04510,8.636419664015231e-156,"19% O2, CyA- vs 1% O2, CyA+",155.06366626243116,Focal adhesion
hsa04668,3.2179554139009466e-18,"19% O2, CyA- vs 1% O2, CyA+",17.492419977524413,TNF signaling pathway
hsa05226,1.3525700671477681e-05,"19% O2, CyA- vs 1% O2, CyA+",4.8688402278942595,Gastric cancer
hsa00770,0.534092348021096,"19% O2, CyA- vs 1% O2, CyA+",0.2723836441540971,Pantothenate and CoA biosynthesis
hsa05131,0.00010333721291685054,"19% O2, CyA- vs 1% O2, CyA+",3.9857432558845622,Shigellosis
hsa01522,0.2028555699656301,"19% O2, CyA- vs 1% O2, CyA+",0.692813063029278,Endocrine resistance
hsa04062,0.4063778126513518,"19% O2, CyA- vs 1% O2, CyA+",0.3910700116152033,Chemokine signaling pathway
hsa04911,0.09905285912271194,"19% O2, CyA- vs 1% O2, CyA+",1.0041329842011928,Insulin secretion
hsa00040,0.5100005563962511,"19% O2, CyA- vs 1% O2, CyA+",0.2924293500987503,Pentose and glucuronate interconversions
hsa04930,0.32521003134282733,"19% O2, CyA- vs 1% O2, CyA+",0.48783606673834856,Type II diabetes mellitus
hsa05202,6.5554299206582364e-09,"19% O2, CyA- vs 1% O2, CyA+",8.183398820976661,Transcriptional misregulation in cancer
hsa05145,0.3120214086654107,"19% O2, CyA- vs 1% O2, CyA+",0.505815606794775,Toxoplasmosis
hsa04380,4.4280140487863583e-07,"19% O2, CyA- vs 1% O2, CyA+",6.353791009902458,Osteoclast differentiation
hsa04010,0.01972939265498321,"19% O2, CyA- vs 1% O2, CyA+",1.7048862837619612,MAPK signaling pathway
hsa05142,0.44579990269124675,"19% O2, CyA- vs 1% O2, CyA+",0.3508600306531323,Chagas disease
hsa00020,0.388645002729513,"19% O2, CyA- vs 1% O2, CyA+",0.4104469121626622,Citrate cycle (TCA cycle)
hsa04744,0.5269311655735937,"19% O2, CyA- vs 1% O2, CyA+",0.2782461141310239,Phototransduction
hsa04921,1.7140412429079697e-05,"19% O2, CyA- vs 1% O2, CyA+",4.765978732382567,Oxytocin signaling pathway
